data_2cqj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cqj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.51 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD21 ' C ' ' A' ' 123' ' ' HIS . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.51 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 145' ' ' ASP . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.505 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG13 ' A' ' 131' ' ' VAL . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 148' ' ' PHE . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.443 ' CB ' HG11 ' A' ' 150' ' ' VAL . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 154' ' ' MET . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.505 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' CD ' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.423 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.423 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 116' ' ' LEU . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' ' CG2' ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.509 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.0 m-70 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG21 ' CZ3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.573 HG23 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.509 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 145' ' ' ASP . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' A' ' 143' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.573 HG23 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CZ3' HG21 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 136' ' ' VAL . 87.2 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.479 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.407 HG11 ' C ' ' A' ' 145' ' ' ASP . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.666 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.454 HG11 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 150' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.666 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.483 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.43 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 ' C ' ' A' ' 145' ' ' ASP . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.511 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.649 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.419 ' NH2' HG23 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG23 ' CE2' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' C ' HG12 ' A' ' 131' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.492 ' CE2' HG23 ' A' ' 143' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.419 HG23 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.649 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.49 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 HD21 ' C ' ' A' ' 123' ' ' HIS . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.462 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 145' ' ' ASP . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.412 ' C ' HG22 ' A' ' 161' ' ' VAL . 23.1 m-70 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.628 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 141' ' ' ASP . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG13 ' A' ' 131' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 143' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.438 ' N ' HG11 ' A' ' 150' ' ' VAL . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.447 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.628 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' C ' ' A' ' 135' ' ' HIS . 24.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.48 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 118' ' ' LEU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.445 HD21 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.425 ' CD1' HG13 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.522 ' HE2' ' CD1' ' A' ' 160' ' ' TRP . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 145' ' ' ASP . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 33.1 m-70 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.693 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.508 HG12 ' CG ' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.42 ' C ' HG12 ' A' ' 131' ' ' VAL . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.508 ' CG ' HG12 ' A' ' 143' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.502 ' SD ' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' CD ' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.693 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.496 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.496 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.422 HG11 ' C ' ' A' ' 145' ' ' ASP . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 148' ' ' PHE . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' C ' HG11 ' A' ' 131' ' ' VAL . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.416 ' CB ' HG12 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.561 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.422 ' HE2' ' NE1' ' A' ' 160' ' ' TRP . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.409 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.484 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 31.1 m-70 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.564 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.494 HG23 ' CE2' ' A' ' 148' ' ' PHE . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.405 HG23 ' CB ' ' A' ' 154' ' ' MET . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.405 ' CB ' HG23 ' A' ' 151' ' ' THR . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.564 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.488 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.482 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.482 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 145' ' ' ASP . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.512 HG21 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.401 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG13 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CD2' HG22 ' A' ' 143' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.555 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.465 ' N ' HG12 ' A' ' 150' ' ' VAL . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.511 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.514 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG21 ' CE3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.412 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CE3' HG21 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.48 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.486 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG12 ' C ' ' A' ' 145' ' ' ASP . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.683 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.46 ' N ' HG12 ' A' ' 143' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG12 ' A' ' 131' ' ' VAL . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.683 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.485 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.46 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 145' ' ' ASP . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.489 HG23 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' C ' HG12 ' A' ' 131' ' ' VAL . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.563 ' CD2' HG22 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 148' ' ' PHE . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.455 ' N ' HG11 ' A' ' 150' ' ' VAL . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.489 ' CE3' HG23 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.496 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 ' CA ' ' A' ' 124' ' ' LEU . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.465 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' CA ' HD11 ' A' ' 116' ' ' LEU . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.442 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' HG21 ' A' ' 143' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.662 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.475 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.475 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.6 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 141' ' ' ASP . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG12 ' A' ' 131' ' ' VAL . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.446 ' N ' HG13 ' A' ' 150' ' ' VAL . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.449 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.6 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.458 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 123' ' ' HIS . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.469 ' HE1' ' NE1' ' A' ' 160' ' ' TRP . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CD2' ' HB1' ' A' ' 126' ' ' ALA . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.424 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.558 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.409 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.456 HG13 ' CG ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.424 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 150' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.535 HG22 ' CE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.469 ' N ' HG13 ' A' ' 150' ' ' VAL . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.409 ' CE ' HG12 ' A' ' 138' ' ' VAL . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.558 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.413 HG11 ' CD ' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.49 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.49 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.419 ' C ' HD23 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.51 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.459 ' CG1' ' HB2' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 138' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 151' ' ' THR . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 150' ' ' VAL . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.446 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.413 ' CD ' HG11 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' A' ' 154' ' ' MET . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.51 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.435 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.464 ' HE2' ' NE1' ' A' ' 160' ' ' TRP . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.475 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.555 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.525 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 151' ' ' THR . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.525 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.505 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.435 ' HE1' ' NE1' ' A' ' 160' ' ' TRP . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.566 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.566 ' CD2' ' HG3' ' A' ' 122' ' ' GLN . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.2 m-70 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.698 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 148' ' ' PHE . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CG ' HG11 ' A' ' 143' ' ' VAL . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.698 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 135' ' ' HIS . 74.7 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.496 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.468 ' CE ' ' NE1' ' A' ' 160' ' ' TRP . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.464 ' CB ' HG11 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 151' ' ' THR . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.45 ' N ' HG13 ' A' ' 150' ' ' VAL . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.503 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.503 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.502 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.9 m-70 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.568 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.467 HG11 ' CB ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.467 ' CB ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.568 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 135' ' ' HIS . 56.0 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -121.69 170.3 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.859 0.361 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -86.12 118.91 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.04 -127.01 0.89 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.46 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -139.64 121.44 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.3 t -106.45 92.77 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.807 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.47 158.64 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.12 159.23 42.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.51 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD21 ' C ' ' A' ' 123' ' ' HIS . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.51 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 145' ' ' ASP . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.505 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG13 ' A' ' 131' ' ' VAL . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 148' ' ' PHE . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.443 ' CB ' HG11 ' A' ' 150' ' ' VAL . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 154' ' ' MET . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.505 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.8 t -41.43 -51.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.89 98.78 4.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.6 p -102.61 34.01 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 t -60.22 -52.07 66.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.18 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 mm -39.07 130.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 77.7 p -83.11 168.49 16.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.21 81.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -11.18 30.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.3 m -83.83 150.98 25.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.824 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.7 p -137.93 135.76 36.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -88.24 143.12 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 t -135.64 151.34 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.29 97.26 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 p -43.33 -53.27 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.954 0.407 . . . . 0.0 110.906 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.8 p 45.9 39.24 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.93 111.69 0.49 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.528 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -120.86 144.1 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' CD ' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.423 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.423 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 116' ' ' LEU . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' ' CG2' ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.509 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.0 m-70 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG21 ' CZ3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.573 HG23 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.509 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 145' ' ' ASP . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.573 ' CD2' HG23 ' A' ' 143' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.573 HG23 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CZ3' HG21 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 136' ' ' VAL . 87.2 t -64.72 -40.73 90.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -134.96 83.91 2.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.3 t -84.65 92.31 8.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.1 p -106.28 84.41 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 58.03 40.72 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.94 129.58 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -46.76 -46.91 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 39.94 -160.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 150.44 68.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.7 t -160.22 155.46 24.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.9 t 48.62 41.54 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.831 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.545 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -115.43 84.53 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -110.46 163.44 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.52 62.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.514 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.8 t -139.55 111.17 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.4 t -97.97 -51.73 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.14 148.86 35.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 -136.96 158.72 43.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.479 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.407 HG11 ' C ' ' A' ' 145' ' ' ASP . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.666 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.454 HG11 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 150' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.666 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.72 -62.99 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 3.8 p-10 -123.5 106.38 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.408 ' HA ' ' CG1' ' A' ' 166' ' ' ILE . 79.2 p -108.06 47.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.5 t -104.75 -51.67 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 166' ' ' ILE . 34.5 tttt -96.72 -49.42 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' LYS . 2.7 pp -36.07 145.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.8 m -69.79 162.99 26.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.19 75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.61 18.64 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 t -96.17 149.38 21.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.8 m 53.93 43.74 30.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.879 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.1 p -38.88 -50.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.8 p -40.38 114.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.13 110.49 2.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.8 p -98.94 108.1 20.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.9 m -57.25 -44.92 84.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.81 148.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -124.44 147.69 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.483 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.43 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 ' C ' ' A' ' 145' ' ' ASP . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.511 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.649 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.419 ' NH2' HG23 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG23 ' CE2' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' C ' HG12 ' A' ' 131' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.492 ' CE2' HG23 ' A' ' 143' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.419 HG23 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.649 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -55.9 -52.48 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.6 93.61 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 94.2 p -113.88 63.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.3 t -107.32 -43.18 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.795 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -129.77 64.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.51 -54.24 7.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.2 p -125.62 146.2 49.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.29 149.66 49.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -17.17 38.23 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.271 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.0 p -141.77 142.11 33.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -39.0 137.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -87.25 90.46 8.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.6 p -125.16 124.83 42.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.7 -151.83 8.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.7 t -118.76 -56.59 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.2 p -136.3 111.59 9.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -118.48 157.7 15.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -129.75 144.39 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.49 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 HD21 ' C ' ' A' ' 123' ' ' HIS . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.462 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 126' ' ' ALA . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 145' ' ' ASP . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.412 ' C ' HG22 ' A' ' 161' ' ' VAL . 23.1 m-70 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.628 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 141' ' ' ASP . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG13 ' A' ' 131' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 143' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.438 ' N ' HG11 ' A' ' 150' ' ' VAL . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.447 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.628 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' C ' ' A' ' 135' ' ' HIS . 24.8 t -41.37 -42.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -112.7 -44.31 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.8 m 60.09 40.51 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.5 t -106.35 -53.85 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.0 OUTLIER -76.03 -55.79 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 165' ' ' LYS . 2.9 pp -33.95 140.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.8 m -127.77 173.99 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.97 -158.2 10.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.38 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.1 t -50.61 -59.22 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.9 p -40.78 129.67 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -163.02 135.96 5.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.843 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -135.43 120.68 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.4 67.82 3.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 156.46 37.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.901 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -104.17 44.38 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.91 146.49 6.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -136.58 151.62 49.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.48 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 118' ' ' LEU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.445 HD21 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.425 ' CD1' HG13 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.522 ' HE2' ' CD1' ' A' ' 160' ' ' TRP . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 145' ' ' ASP . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.419 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 33.1 m-70 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.693 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.508 HG12 ' CG ' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.42 ' C ' HG12 ' A' ' 131' ' ' VAL . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.508 ' CG ' HG12 ' A' ' 143' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.502 ' SD ' ' CG1' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' CD ' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.693 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.43 -56.73 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.86 94.08 4.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.7 t -109.49 81.69 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.6 p -100.89 87.33 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 59.87 40.48 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.07 162.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.1 t -80.69 104.23 11.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.13 -172.91 13.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 99.98 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.0 m -52.96 159.49 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -70.37 127.34 32.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.0 p -95.52 89.72 5.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m -53.1 128.02 26.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -53.46 103.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 m -133.25 84.14 2.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.9 m -43.82 124.95 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -52.82 151.22 8.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 -137.09 155.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.484 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.496 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.496 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.422 HG11 ' C ' ' A' ' 145' ' ' ASP . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 148' ' ' PHE . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' C ' HG11 ' A' ' 131' ' ' VAL . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.416 ' CB ' HG12 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.561 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.87 -54.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.84 -46.56 5.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 2.3 t 62.14 31.01 17.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.5 p -50.6 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -70.59 -39.47 73.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 160' ' ' TRP . 4.1 mp -45.44 119.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.7 m -39.07 -58.68 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.2 173.53 14.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.57 2.42 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.767 2.311 . . . . 0.0 112.378 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 m -63.46 -60.53 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.782 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.2 m -59.28 117.34 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.453 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -78.61 129.47 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -90.24 82.88 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.13 69.68 0.5 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.8 m -65.16 93.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.4 m -40.87 -63.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.14 166.7 12.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -126.75 147.37 49.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.409 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.422 ' HE2' ' NE1' ' A' ' 160' ' ' TRP . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.409 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.484 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.446 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 31.1 m-70 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.564 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.494 HG23 ' CE2' ' A' ' 148' ' ' PHE . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.405 HG23 ' CB ' ' A' ' 154' ' ' MET . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.405 ' CB ' HG23 ' A' ' 151' ' ' THR . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.564 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.92 -39.96 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -137.85 107.45 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.3 p -124.85 76.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.6 m -100.17 88.39 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt 57.57 36.49 26.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 167' ' ' SER . 2.0 pp -87.24 -21.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.428 ' N ' HD11 ' A' ' 166' ' ' ILE . 23.1 t -94.36 94.23 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.66 -159.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -4.66 14.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.691 2.261 . . . . 0.0 112.304 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 t -47.42 134.22 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 77.1 p -59.42 106.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -104.56 127.49 52.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.375 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.9 m -91.75 112.08 23.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.46 171.67 41.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.477 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.8 t -114.6 -58.63 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -112.11 169.42 8.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.17 175.4 17.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 -126.18 158.49 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.488 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.482 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.482 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 145' ' ' ASP . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.512 HG21 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.401 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG13 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CD2' HG22 ' A' ' 143' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.555 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.465 ' N ' HG12 ' A' ' 150' ' ' VAL . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t -41.43 -50.76 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -97.73 -51.77 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t 56.35 46.94 20.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.7 m -121.12 -45.97 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -102.21 40.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.916 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 mm -81.69 54.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.7 t -67.9 103.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -144.5 144.8 13.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -23.12 31.45 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -39.06 152.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 t -123.94 145.57 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -52.07 -43.93 64.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 m -92.93 -46.53 7.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.31 -105.75 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.9 p -113.69 175.64 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -116.35 121.67 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.66 170.86 27.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -111.24 138.9 47.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.511 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.514 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG21 ' CE3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CE3' HG21 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t -53.18 -51.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.03 107.75 13.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 166' ' ' ILE . 72.9 p -121.55 94.25 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -122.9 95.84 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? 52.82 45.28 29.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 163' ' ' SER . 75.4 mt -67.99 112.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.1 m -75.16 173.41 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.89 -161.98 19.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 117.72 5.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.748 2.299 . . . . 0.0 112.255 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.3 p -98.32 139.67 33.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.833 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.2 m -125.47 -52.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.413 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -115.97 169.98 8.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -117.04 100.85 8.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.34 -52.65 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.447 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -112.75 153.76 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -142.34 124.92 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.88 172.68 46.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -137.13 153.58 50.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.48 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.486 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG12 ' C ' ' A' ' 145' ' ' ASP . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.683 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.46 ' N ' HG12 ' A' ' 143' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG12 ' A' ' 131' ' ' VAL . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.683 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t -41.61 -69.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -127.44 92.69 3.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.1 p -120.12 36.14 4.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -66.52 -60.2 2.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.84 -33.09 68.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 24.4 mm -50.98 130.56 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.111 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 p 40.86 43.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -74.83 -169.29 23.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 170' ' ' SER . 53.9 Cg_endo -69.73 -9.37 25.94 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 169' ' ' PRO . 91.5 p -37.78 121.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -127.51 132.02 50.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 m -87.21 135.59 33.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -68.82 120.25 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 173.23 40.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.461 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.2 m -78.67 121.18 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -125.09 -47.61 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.07 137.26 2.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -136.73 156.21 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.485 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.46 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 145' ' ' ASP . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.489 HG23 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' C ' HG12 ' A' ' 131' ' ' VAL . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.563 ' CD2' HG22 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 148' ' ' PHE . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.455 ' N ' HG11 ' A' ' 150' ' ' VAL . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.489 ' CE3' HG23 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.5 t -43.66 -25.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -147.52 108.67 4.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.11 89.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.1 t -118.93 94.06 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 38.2 mttm 54.19 35.34 22.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.28 -53.34 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.1 t -62.07 137.81 58.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.99 -87.26 1.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 102.42 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.659 2.24 . . . . 0.0 112.28 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 89.8 p -108.89 85.56 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.1 t -59.53 -50.09 75.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.527 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.3 p -92.96 82.13 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.7 p -121.09 172.12 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.99 -64.61 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.3 m -142.98 166.47 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -40.32 -44.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -97.12 132.95 11.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -126.78 151.04 48.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.496 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 ' CA ' ' A' ' 124' ' ' LEU . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.465 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' CA ' HD11 ' A' ' 116' ' ' LEU . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.442 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' HG21 ' A' ' 143' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.662 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.4 t -39.87 -41.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.44 88.35 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.9 p -101.2 40.71 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -94.99 -46.4 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 166' ' ' ILE . 22.2 tptp -72.33 -36.49 68.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 165' ' ' LYS . 47.3 mm -37.36 126.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.103 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -141.02 110.68 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.62 83.15 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.88 118.94 5.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.284 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 34.5 m -76.17 124.58 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 62.2 p -66.89 114.73 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.0 p -75.48 146.85 40.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.377 . . . . 0.0 110.81 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -169.74 124.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.48 123.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.0 p -143.37 171.79 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m -125.56 50.77 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.32 140.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.533 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -129.21 158.15 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.475 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.6 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 141' ' ' ASP . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' C ' HG12 ' A' ' 131' ' ' VAL . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.446 ' N ' HG13 ' A' ' 150' ' ' VAL . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.449 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.6 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.23 -45.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.97 111.79 14.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 89.3 p -124.31 42.73 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.1 t -79.11 -44.82 21.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -83.37 -34.35 25.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.25 122.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 t -156.88 138.38 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.06 -159.83 16.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.1 20.19 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.9 p -41.39 151.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.4 p -113.68 112.71 23.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.485 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 m -43.48 126.49 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -164.62 127.62 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.79 144.16 46.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -68.0 -53.75 23.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.865 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.9 p -156.15 154.92 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.63 177.72 39.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.492 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -133.87 142.1 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.458 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 123' ' ' HIS . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.469 ' HE1' ' NE1' ' A' ' 160' ' ' TRP . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CD2' ' HB1' ' A' ' 126' ' ' ALA . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.424 ' CG1' ' C ' ' A' ' 145' ' ' ASP . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.558 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.409 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.456 HG13 ' CG ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.424 ' C ' ' CG1' ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 150' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.535 HG22 ' CE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.469 ' N ' HG13 ' A' ' 150' ' ' VAL . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.409 ' CE ' HG12 ' A' ' 138' ' ' VAL . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.558 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.59 -40.65 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -140.51 109.68 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 166' ' ' ILE . 49.6 p -109.8 66.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -87.51 -75.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 17.0 tttp -68.66 -40.39 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 165' ' ' LYS . 5.2 mp -33.43 112.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.4 t -137.53 121.34 17.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.25 -159.16 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 120.53 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.698 2.266 . . . . 0.0 112.34 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.5 p -59.1 -46.39 88.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 68.4 m 62.01 41.19 11.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.555 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.2 m 62.62 43.41 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m -113.44 174.61 5.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.21 -45.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.549 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 171.26 10.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.927 0.394 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.9 m -69.19 158.86 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.42 137.23 4.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -127.49 153.19 46.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.413 HG11 ' CD ' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.49 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.49 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.419 ' C ' HD23 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.51 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.459 ' CG1' ' HB2' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 138' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 151' ' ' THR . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 150' ' ' VAL . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.446 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.413 ' CD ' HG11 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' A' ' 154' ' ' MET . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.51 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.6 t -46.18 -68.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.23 -60.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 160' ' ' TRP . 68.1 p 49.72 39.49 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 12.2 m -109.32 -53.65 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -107.92 28.58 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.8 mt -106.42 73.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 t -66.27 176.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.46 163.71 9.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 84.84 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.405 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.1 t -47.36 -53.37 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.799 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -165.57 167.32 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 t -84.19 -49.43 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 p -167.4 125.21 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.72 -126.41 0.84 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -94.7 164.91 12.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -52.11 139.47 23.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.19 117.65 2.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -132.02 158.98 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.435 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.464 ' HE2' ' NE1' ' A' ' 160' ' ' TRP . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.475 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.555 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.525 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 151' ' ' THR . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.525 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -37.17 -32.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 160' ' ' TRP . 35.5 m-20 -150.26 106.57 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.3 m -106.53 86.32 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.4 t -112.33 84.88 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.1 tttp 61.32 45.53 8.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.5 123.85 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 65.2 p -126.84 172.15 10.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.92 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.68 146.09 59.63 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.0 m -51.01 -39.67 56.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.8 t -68.23 124.82 24.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -90.18 85.84 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.824 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -89.21 123.81 33.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.57 89.83 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.521 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -98.46 167.66 10.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.893 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.8 p -116.23 110.91 19.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.03 149.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -133.46 150.36 51.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.505 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.435 ' HE1' ' NE1' ' A' ' 160' ' ' TRP . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.566 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.566 ' CD2' ' HG3' ' A' ' 122' ' ' GLN . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.2 m-70 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.698 ' CG2' ' CZ3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 148' ' ' PHE . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CG ' HG11 ' A' ' 143' ' ' VAL . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.698 ' CZ3' ' CG2' ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 135' ' ' HIS . 74.7 t -53.77 -56.18 10.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -121.86 -54.39 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 t 62.41 46.85 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.3 t -105.24 -45.42 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -128.54 37.04 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.2 pp -91.12 167.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 p -105.32 119.91 40.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -164.06 -156.3 8.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 2.82 3.2 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.624 2.216 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -40.14 -42.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 71.8 m -141.0 150.16 42.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.5 p -100.14 158.35 15.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.0 m -143.38 150.2 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.66 -46.63 1.02 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -79.99 170.41 16.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.841 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 m -127.6 -65.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -124.98 146.25 16.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.533 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -133.02 154.99 50.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.496 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.468 ' CE ' ' NE1' ' A' ' 160' ' ' TRP . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.464 ' CB ' HG11 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 151' ' ' THR . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.45 ' N ' HG13 ' A' ' 150' ' ' VAL . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.567 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.45 -54.68 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -109.72 -32.09 7.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -87.67 38.26 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -71.73 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' ILE . 13.0 tptm -58.26 -48.41 80.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 165' ' ' LYS . 48.3 mm -35.2 -49.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.21 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.7 p -122.57 102.29 7.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 164.36 83.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -1.85 9.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.278 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 66.6 m -44.08 130.3 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.2 t -56.95 -57.22 13.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.519 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.2 p -101.62 89.89 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m -108.13 96.1 6.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.06 -53.54 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.41 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.7 p -51.35 -38.48 53.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.3 p -80.48 138.43 36.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.37 116.82 1.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -123.49 154.73 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' CD2' ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.503 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.502 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.9 m-70 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.568 HG23 ' CZ3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.467 HG11 ' CB ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.467 ' CB ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.568 ' CZ3' HG23 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 135' ' ' HIS . 56.0 t -37.3 -48.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -131.62 111.49 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.3 p -103.7 51.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 t -88.88 -59.88 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -122.85 41.39 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 2.2 pp -86.61 160.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 53.4 p -73.69 100.37 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.47 147.21 4.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.85 -14.62 36.03 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.232 . . . . 0.0 112.272 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 p 52.7 41.46 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.5 t -87.57 112.93 22.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.487 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 124' ' ' LEU . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.656 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.446 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 146' ' ' PRO . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 127' ' ' ALA . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.601 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.579 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.431 HG21 ' HE2' ' A' ' 148' ' ' PHE . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.904 HG21 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.904 ' CD2' HG21 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 154' ' ' MET . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.52 ' H ' HG23 ' A' ' 151' ' ' THR . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.579 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 134' ' ' GLY . 67.8 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.605 HG13 ' OE1' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.429 HD21 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.701 ' CB ' HD23 ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.867 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 127' ' ' ALA . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.704 HG22 ' CE3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.498 ' HB3' HG22 ' A' ' 161' ' ' VAL . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 140' ' ' PRO . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 139' ' ' GLY . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.577 HG21 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.606 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.477 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 138' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.605 ' OE1' HG13 ' A' ' 114' ' ' VAL . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.704 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.522 HG23 ' CA ' ' A' ' 136' ' ' VAL . 87.2 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' A' ' 124' ' ' LEU . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.687 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' A' ' 116' ' ' LEU . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 124' ' ' LEU . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.849 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.592 HG12 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.685 ' CD2' HG21 ' A' ' 143' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.619 ' H ' HG23 ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.433 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 155' ' ' GLU . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.849 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 118' ' ' LEU . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD11 ' HA ' ' A' ' 124' ' ' LEU . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.541 HD12 HG12 ' A' ' 114' ' ' VAL . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.724 ' HB2' HD23 ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.491 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.583 ' HA ' HD11 ' A' ' 116' ' ' LEU . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 124' ' ' LEU . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 127' ' ' ALA . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.533 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG22 ' CE3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.413 ' NH2' HG21 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.788 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.643 HG11 ' CG ' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 143' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.788 ' HE2' HG21 ' A' ' 138' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 150' ' ' VAL . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.413 HG21 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.77 ' CE3' HG22 ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' A' ' 124' ' ' LEU . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.64 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.501 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 128' ' ' VAL . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.905 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 124' ' ' LEU . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 127' ' ' ALA . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.526 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.866 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.732 HG21 ' HE2' ' A' ' 148' ' ' PHE . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.508 ' H ' HG12 ' A' ' 143' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.732 ' HE2' HG21 ' A' ' 138' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.588 ' HB3' HG13 ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.866 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 134' ' ' GLY . 24.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.859 HG11 ' OE1' ' A' ' 155' ' ' GLU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.649 HD23 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.649 ' CB ' HD23 ' A' ' 115' ' ' LEU . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.61 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.77 ' HA ' HD11 ' A' ' 116' ' ' LEU . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 124' ' ' LEU . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 127' ' ' ALA . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.797 HG22 ' CE3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG21 ' CE2' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 150' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 148' ' ' PHE . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.585 ' HB3' HG12 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.859 ' OE1' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.797 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 118' ' ' LEU . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 124' ' ' LEU . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 114' ' ' VAL . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.689 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.486 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' A' ' 116' ' ' LEU . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 146' ' ' PRO . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 127' ' ' ALA . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 145' ' ' ASP . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HG3' HG13 ' A' ' 128' ' ' VAL . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.537 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.514 ' HB3' HG13 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.44 HG13 ' OE1' ' A' ' 155' ' ' GLU . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.669 ' CB ' HD23 ' A' ' 115' ' ' LEU . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 128' ' ' VAL . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 127' ' ' ALA . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.508 ' C ' HG23 ' A' ' 161' ' ' VAL . 10.6 m80 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.749 HG22 ' CE3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.761 HG21 ' CD2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.642 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.525 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 154' ' ' MET . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.7 ' HG2' HG13 ' A' ' 150' ' ' VAL . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 114' ' ' VAL . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.749 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 135' ' ' HIS . 85.6 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 118' ' ' LEU . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.921 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 114' ' ' VAL . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.626 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.723 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.921 ' HA ' HD11 ' A' ' 116' ' ' LEU . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 123' ' ' HIS . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 124' ' ' LEU . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 127' ' ' ALA . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 148' ' ' PHE . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' C ' HG11 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 150' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 154' ' ' MET . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.45 ' H ' HG23 ' A' ' 151' ' ' THR . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 155' ' ' GLU . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.504 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.513 HD21 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.622 ' CB ' HD23 ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 128' ' ' VAL . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 124' ' ' LEU . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 127' ' ' ALA . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.546 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.43 HG21 ' CE2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.647 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.552 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD21 ' C ' ' A' ' 123' ' ' HIS . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.641 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 116' ' ' LEU . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 146' ' ' PRO . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 127' ' ' ALA . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.015 HG22 ' CE3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' A' ' 148' ' ' PHE . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 131' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 148' ' ' PHE . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 158' ' ' VAL . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 155' ' ' GLU . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 1.015 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.717 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 123' ' ' HIS . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.717 ' CB ' HD23 ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.57 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 128' ' ' VAL . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 124' ' ' LEU . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 127' ' ' ALA . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.658 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.41 ' C ' HG23 ' A' ' 161' ' ' VAL . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.679 HG22 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.599 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.87 HG21 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.87 ' CD2' HG21 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 154' ' ' MET . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 154' ' ' MET . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.542 ' CB ' HG13 ' A' ' 150' ' ' VAL . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 134' ' ' GLY . 87.5 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.494 HH21 HG22 ' A' ' 113' ' ' THR . 6.9 ptm180 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.667 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.494 HG22 HH21 ' A' ' 109' ' ' ARG . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 118' ' ' LEU . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.82 HD21 ' C ' ' A' ' 123' ' ' HIS . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 114' ' ' VAL . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.756 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.82 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.753 ' O ' HG23 ' A' ' 128' ' ' VAL . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.667 HG22 HD23 ' A' ' 111' ' ' LEU . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.796 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 161' ' ' VAL . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.64 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' C ' HG11 ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 138' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.796 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 137' ' ' ARG . 62.4 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 155' ' ' GLU . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.693 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.693 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.506 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 116' ' ' LEU . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.783 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.463 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.624 ' HB3' HG13 ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 158' ' ' VAL . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 155' ' ' GLU . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.783 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.515 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 110' ' ' ARG . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 124' ' ' LEU . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 114' ' ' VAL . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.631 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 128' ' ' VAL . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.864 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 124' ' ' LEU . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.706 HG22 ' CE3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.502 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.603 HG11 ' CB ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.534 ' C ' HG11 ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.603 ' CB ' HG11 ' A' ' 143' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.478 HG22 ' HE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 154' ' ' MET . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.687 ' H ' HG23 ' A' ' 151' ' ' THR . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 134' ' ' GLY . 78.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.51 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' OE2' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.574 HD23 ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.546 HD21 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.574 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.546 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.531 ' HA ' HD11 ' A' ' 116' ' ' LEU . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.513 ' HB2' ' NE2' ' A' ' 123' ' ' HIS . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 127' ' ' ALA . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.647 ' C ' HG23 ' A' ' 161' ' ' VAL . 6.7 m80 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.606 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.712 ' CB ' HG11 ' A' ' 143' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 154' ' ' MET . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.765 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.606 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.647 HG23 ' C ' ' A' ' 135' ' ' HIS . 96.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.497 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 118' ' ' LEU . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.702 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 124' ' ' LEU . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 114' ' ' VAL . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.702 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.63 HG22 HD23 ' A' ' 111' ' ' LEU . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.584 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.786 HG21 ' CD2' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.524 ' H ' HG23 ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 138' ' ' VAL . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.584 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' OE2' ' A' ' 155' ' ' GLU . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.832 HD21 ' C ' ' A' ' 123' ' ' HIS . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.664 ' HB2' HD23 ' A' ' 115' ' ' LEU . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.832 ' C ' HD21 ' A' ' 116' ' ' LEU . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 124' ' ' LEU . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.655 HG22 HD23 ' A' ' 111' ' ' LEU . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.567 ' C ' HG23 ' A' ' 161' ' ' VAL . 7.6 m80 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.752 HG22 ' CE3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 145' ' ' ASP . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' H ' HG12 ' A' ' 143' ' ' VAL . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.482 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 154' ' ' MET . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.771 ' CB ' HG13 ' A' ' 150' ' ' VAL . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' HG12 ' A' ' 150' ' ' VAL . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.752 ' CE3' HG22 ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 135' ' ' HIS . 74.7 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.509 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.444 HD21 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 128' ' ' VAL . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 127' ' ' ALA . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.739 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 148' ' ' PHE . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.582 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.495 ' CD2' HG21 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 154' ' ' MET . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' MET . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 150' ' ' VAL . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' VAL . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 155' ' ' GLU . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.739 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.512 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.423 HG21 ' HB ' ' A' ' 150' ' ' VAL . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.625 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 123' ' ' HIS . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.625 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 128' ' ' VAL . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 127' ' ' ALA . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.567 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.674 HG22 ' CE3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.575 HG11 ' CG ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.443 ' C ' HG12 ' A' ' 131' ' ' VAL . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CG ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.767 HG13 ' CB ' ' A' ' 154' ' ' MET . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.767 ' CB ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 150' ' ' VAL . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' MET . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 134' ' ' GLY . 56.0 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -121.69 170.3 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.859 0.361 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -86.12 118.91 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.04 -127.01 0.89 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.46 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -139.64 121.44 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.3 t -106.45 92.77 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.807 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.47 158.64 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.12 159.23 42.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.487 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 124' ' ' LEU . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.656 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.446 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 146' ' ' PRO . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 127' ' ' ALA . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.601 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.579 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG21 ' HE2' ' A' ' 148' ' ' PHE . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.904 HG21 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.904 ' CD2' HG21 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 154' ' ' MET . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.52 ' H ' HG23 ' A' ' 151' ' ' THR . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.579 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 134' ' ' GLY . 67.8 t -41.43 -51.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.89 98.78 4.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.6 p -102.61 34.01 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 t -60.22 -52.07 66.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.18 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 mm -39.07 130.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 77.7 p -83.11 168.49 16.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.21 81.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -11.18 30.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.3 m -83.83 150.98 25.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.824 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.7 p -137.93 135.76 36.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -88.24 143.12 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 t -135.64 151.34 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.29 97.26 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 p -43.33 -53.27 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.954 0.407 . . . . 0.0 110.906 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.8 p 45.9 39.24 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.93 111.69 0.49 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.528 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -120.86 144.1 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.605 HG13 ' OE1' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD21 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.701 ' CB ' HD23 ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.867 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 127' ' ' ALA . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.704 HG22 ' CE3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.498 ' HB3' HG22 ' A' ' 161' ' ' VAL . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 140' ' ' PRO . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 139' ' ' GLY . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.577 HG21 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.606 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.477 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 138' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.605 ' OE1' HG13 ' A' ' 114' ' ' VAL . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.704 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.522 HG23 ' CA ' ' A' ' 136' ' ' VAL . 87.2 t -64.72 -40.73 90.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -134.96 83.91 2.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.3 t -84.65 92.31 8.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.1 p -106.28 84.41 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 58.03 40.72 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.94 129.58 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -46.76 -46.91 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 39.94 -160.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 150.44 68.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.7 t -160.22 155.46 24.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.9 t 48.62 41.54 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.831 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.545 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -115.43 84.53 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -110.46 163.44 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.52 62.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.514 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.8 t -139.55 111.17 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.4 t -97.97 -51.73 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.14 148.86 35.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 -136.96 158.72 43.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' A' ' 124' ' ' LEU . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.687 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' A' ' 116' ' ' LEU . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 124' ' ' LEU . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.849 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.592 HG12 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.685 ' CD2' HG21 ' A' ' 143' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.619 ' H ' HG23 ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 155' ' ' GLU . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.849 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.72 -62.99 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 3.8 p-10 -123.5 106.38 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.418 ' HA ' ' CG1' ' A' ' 166' ' ' ILE . 79.2 p -108.06 47.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.5 t -104.75 -51.67 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 166' ' ' ILE . 34.5 tttt -96.72 -49.42 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.7 pp -36.07 145.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.8 m -69.79 162.99 26.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.19 75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.61 18.64 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 t -96.17 149.38 21.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.8 m 53.93 43.74 30.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.879 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.1 p -38.88 -50.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.8 p -40.38 114.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.13 110.49 2.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.8 p -98.94 108.1 20.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.9 m -57.25 -44.92 84.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.81 148.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -124.44 147.69 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 118' ' ' LEU . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD11 ' HA ' ' A' ' 124' ' ' LEU . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.541 HD12 HG12 ' A' ' 114' ' ' VAL . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.724 ' HB2' HD23 ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.491 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.583 ' HA ' HD11 ' A' ' 116' ' ' LEU . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 124' ' ' LEU . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 127' ' ' ALA . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.533 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG22 ' CE3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.413 ' NH2' HG21 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.788 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.643 HG11 ' CG ' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 143' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.788 ' HE2' HG21 ' A' ' 138' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 150' ' ' VAL . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.413 HG21 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.77 ' CE3' HG22 ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -55.9 -52.48 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.6 93.61 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.481 ' HA ' HD11 ' A' ' 166' ' ' ILE . 94.2 p -113.88 63.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.3 t -107.32 -43.18 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.795 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -129.77 64.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 163' ' ' SER . 74.9 mt -94.51 -54.24 7.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.2 p -125.62 146.2 49.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.29 149.66 49.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -17.17 38.23 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.271 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.0 p -141.77 142.11 33.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -39.0 137.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -87.25 90.46 8.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.6 p -125.16 124.83 42.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.7 -151.83 8.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.7 t -118.76 -56.59 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.2 p -136.3 111.59 9.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -118.48 157.7 15.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -129.75 144.39 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' A' ' 124' ' ' LEU . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.64 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.501 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 128' ' ' VAL . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.905 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 124' ' ' LEU . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 127' ' ' ALA . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.526 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.866 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.732 HG21 ' HE2' ' A' ' 148' ' ' PHE . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.508 ' H ' HG12 ' A' ' 143' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.732 ' HE2' HG21 ' A' ' 138' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.588 ' HB3' HG13 ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.866 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 134' ' ' GLY . 24.8 t -41.37 -42.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -112.7 -44.31 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.8 m 60.09 40.51 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.5 t -106.35 -53.85 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.0 OUTLIER -76.03 -55.79 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.694 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.9 pp -33.95 140.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.8 m -127.77 173.99 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.97 -158.2 10.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.38 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.1 t -50.61 -59.22 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.9 p -40.78 129.67 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -163.02 135.96 5.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.843 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -135.43 120.68 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.4 67.82 3.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 156.46 37.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.901 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -104.17 44.38 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.91 146.49 6.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -136.58 151.62 49.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.859 HG11 ' OE1' ' A' ' 155' ' ' GLU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.649 HD23 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.649 ' CB ' HD23 ' A' ' 115' ' ' LEU . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.61 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.77 ' HA ' HD11 ' A' ' 116' ' ' LEU . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 124' ' ' LEU . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 127' ' ' ALA . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.797 HG22 ' CE3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG21 ' CE2' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 150' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 148' ' ' PHE . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.585 ' HB3' HG12 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.859 ' OE1' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.797 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.43 -56.73 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.86 94.08 4.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.7 t -109.49 81.69 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.6 p -100.89 87.33 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 59.87 40.48 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp -88.07 162.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.1 t -80.69 104.23 11.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.13 -172.91 13.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 99.98 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.0 m -52.96 159.49 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -70.37 127.34 32.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.0 p -95.52 89.72 5.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m -53.1 128.02 26.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -53.46 103.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 m -133.25 84.14 2.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.9 m -43.82 124.95 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -52.82 151.22 8.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 -137.09 155.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 118' ' ' LEU . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 124' ' ' LEU . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 114' ' ' VAL . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.689 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.486 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' A' ' 116' ' ' LEU . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 146' ' ' PRO . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 127' ' ' ALA . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 145' ' ' ASP . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HG3' HG13 ' A' ' 128' ' ' VAL . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.537 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.514 ' HB3' HG13 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.87 -54.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.84 -46.56 5.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' HD13 ' A' ' 166' ' ' ILE . 2.3 t 62.14 31.01 17.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.5 p -50.6 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -70.59 -39.47 73.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 166' ' ' ILE . 4.1 mp -45.44 119.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.7 m -39.07 -58.68 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.2 173.53 14.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.57 2.42 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.767 2.311 . . . . 0.0 112.378 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 m -63.46 -60.53 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.782 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.2 m -59.28 117.34 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.453 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -78.61 129.47 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -90.24 82.88 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.13 69.68 0.5 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.8 m -65.16 93.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.4 m -40.87 -63.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.14 166.7 12.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -126.75 147.37 49.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.44 HG13 ' OE1' ' A' ' 155' ' ' GLU . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.669 ' CB ' HD23 ' A' ' 115' ' ' LEU . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 128' ' ' VAL . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 127' ' ' ALA . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.508 ' C ' HG23 ' A' ' 161' ' ' VAL . 10.6 m80 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.749 HG22 ' CE3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.761 HG21 ' CD2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.642 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.525 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 154' ' ' MET . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.7 ' HG2' HG13 ' A' ' 150' ' ' VAL . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 114' ' ' VAL . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.749 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 135' ' ' HIS . 85.6 t -47.92 -39.96 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -137.85 107.45 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.3 p -124.85 76.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.6 m -100.17 88.39 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt 57.57 36.49 26.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.0 pp -87.24 -21.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.424 ' N ' HD12 ' A' ' 166' ' ' ILE . 23.1 t -94.36 94.23 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.66 -159.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -4.66 14.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.691 2.261 . . . . 0.0 112.304 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 t -47.42 134.22 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 77.1 p -59.42 106.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -104.56 127.49 52.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.375 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.9 m -91.75 112.08 23.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.46 171.67 41.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.477 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.8 t -114.6 -58.63 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -112.11 169.42 8.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.17 175.4 17.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 -126.18 158.49 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 118' ' ' LEU . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.921 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 114' ' ' VAL . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.626 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.723 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.921 ' HA ' HD11 ' A' ' 116' ' ' LEU . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 123' ' ' HIS . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 124' ' ' LEU . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 127' ' ' ALA . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 148' ' ' PHE . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' C ' HG11 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 150' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 154' ' ' MET . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.45 ' H ' HG23 ' A' ' 151' ' ' THR . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 155' ' ' GLU . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t -41.43 -50.76 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -97.73 -51.77 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t 56.35 46.94 20.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.7 m -121.12 -45.97 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -102.21 40.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.916 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 166' ' ' ILE . 42.0 mm -81.69 54.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.7 t -67.9 103.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -144.5 144.8 13.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -23.12 31.45 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -39.06 152.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 t -123.94 145.57 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -52.07 -43.93 64.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 m -92.93 -46.53 7.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.31 -105.75 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.9 p -113.69 175.64 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -116.35 121.67 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.66 170.86 27.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -111.24 138.9 47.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.504 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD21 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.622 ' CB ' HD23 ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 128' ' ' VAL . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 124' ' ' LEU . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 127' ' ' ALA . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.546 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.43 HG21 ' CE2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.647 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.552 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t -53.18 -51.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.03 107.75 13.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 166' ' ' ILE . 72.9 p -121.55 94.25 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -122.9 95.84 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? 52.82 45.28 29.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 163' ' ' SER . 75.4 mt -67.99 112.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.1 m -75.16 173.41 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.89 -161.98 19.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 117.72 5.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.748 2.299 . . . . 0.0 112.255 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.3 p -98.32 139.67 33.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.833 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.2 m -125.47 -52.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.413 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -115.97 169.98 8.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -117.04 100.85 8.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.34 -52.65 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.447 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -112.75 153.76 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -142.34 124.92 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.88 172.68 46.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -137.13 153.58 50.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD21 ' C ' ' A' ' 123' ' ' HIS . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.641 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 116' ' ' LEU . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 146' ' ' PRO . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 127' ' ' ALA . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.015 HG22 ' CE3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' A' ' 148' ' ' PHE . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 131' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 148' ' ' PHE . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 158' ' ' VAL . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 155' ' ' GLU . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 1.015 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t -41.61 -69.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -127.44 92.69 3.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.1 p -120.12 36.14 4.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -66.52 -60.2 2.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.84 -33.09 68.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 24.4 mm -50.98 130.56 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.111 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 p 40.86 43.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -74.83 -169.29 23.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 170' ' ' SER . 53.9 Cg_endo -69.73 -9.37 25.94 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 169' ' ' PRO . 91.5 p -37.78 121.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -127.51 132.02 50.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 m -87.21 135.59 33.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -68.82 120.25 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 173.23 40.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.461 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.2 m -78.67 121.18 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -125.09 -47.61 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.07 137.26 2.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -136.73 156.21 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.717 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 123' ' ' HIS . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.717 ' CB ' HD23 ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.57 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 128' ' ' VAL . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 124' ' ' LEU . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 127' ' ' ALA . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.658 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' C ' HG23 ' A' ' 161' ' ' VAL . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.679 HG22 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.599 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.87 HG21 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.87 ' CD2' HG21 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 154' ' ' MET . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 154' ' ' MET . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.542 ' CB ' HG13 ' A' ' 150' ' ' VAL . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 134' ' ' GLY . 87.5 t -43.66 -25.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -147.52 108.67 4.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.11 89.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.1 t -118.93 94.06 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 38.2 mttm 54.19 35.34 22.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.28 -53.34 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.1 t -62.07 137.81 58.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.99 -87.26 1.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 102.42 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.659 2.24 . . . . 0.0 112.28 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 89.8 p -108.89 85.56 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.1 t -59.53 -50.09 75.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.527 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.3 p -92.96 82.13 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.7 p -121.09 172.12 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.99 -64.61 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.3 m -142.98 166.47 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -40.32 -44.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -97.12 132.95 11.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.494 HH21 HG22 ' A' ' 113' ' ' THR . 6.9 ptm180 -126.78 151.04 48.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.667 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.494 HG22 HH21 ' A' ' 109' ' ' ARG . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 118' ' ' LEU . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.82 HD21 ' C ' ' A' ' 123' ' ' HIS . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 114' ' ' VAL . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.756 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.82 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.753 ' O ' HG23 ' A' ' 128' ' ' VAL . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.667 HG22 HD23 ' A' ' 111' ' ' LEU . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.796 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 161' ' ' VAL . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.64 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' C ' HG11 ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 138' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.796 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 137' ' ' ARG . 62.4 t -39.87 -41.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.44 88.35 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.9 p -101.2 40.71 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -94.99 -46.4 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 166' ' ' ILE . 22.2 tptp -72.33 -36.49 68.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 165' ' ' LYS . 47.3 mm -37.36 126.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.103 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -141.02 110.68 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.62 83.15 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.88 118.94 5.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.284 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 34.5 m -76.17 124.58 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 62.2 p -66.89 114.73 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.0 p -75.48 146.85 40.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.377 . . . . 0.0 110.81 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -169.74 124.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.48 123.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.0 p -143.37 171.79 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m -125.56 50.77 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.32 140.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.533 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -129.21 158.15 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 155' ' ' GLU . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.693 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.693 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.506 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 116' ' ' LEU . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.783 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.463 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.624 ' HB3' HG13 ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 158' ' ' VAL . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 155' ' ' GLU . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.783 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.23 -45.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.97 111.79 14.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 89.3 p -124.31 42.73 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.1 t -79.11 -44.82 21.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -83.37 -34.35 25.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.25 122.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 t -156.88 138.38 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.06 -159.83 16.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.1 20.19 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.9 p -41.39 151.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.4 p -113.68 112.71 23.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.485 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 m -43.48 126.49 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -164.62 127.62 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.79 144.16 46.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -68.0 -53.75 23.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.865 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.9 p -156.15 154.92 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.63 177.72 39.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.492 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -133.87 142.1 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 110' ' ' ARG . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 124' ' ' LEU . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 114' ' ' VAL . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.631 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.601 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 128' ' ' VAL . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.864 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 124' ' ' LEU . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.706 HG22 ' CE3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.502 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.603 HG11 ' CB ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' C ' HG11 ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.603 ' CB ' HG11 ' A' ' 143' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.478 HG22 ' HE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 154' ' ' MET . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.687 ' H ' HG23 ' A' ' 151' ' ' THR . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 134' ' ' GLY . 78.7 t -55.59 -40.65 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -140.51 109.68 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.989 ' HA ' HD13 ' A' ' 166' ' ' ILE . 49.6 p -109.8 66.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -87.51 -75.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 17.0 tttp -68.66 -40.39 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.989 HD13 ' HA ' ' A' ' 163' ' ' SER . 5.2 mp -33.43 112.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.4 t -137.53 121.34 17.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.25 -159.16 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 120.53 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.698 2.266 . . . . 0.0 112.34 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.5 p -59.1 -46.39 88.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 68.4 m 62.01 41.19 11.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.555 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.2 m 62.62 43.41 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m -113.44 174.61 5.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.21 -45.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.549 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 171.26 10.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.927 0.394 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.9 m -69.19 158.86 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.42 137.23 4.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -127.49 153.19 46.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.51 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' OE2' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.574 HD23 ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.546 HD21 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.574 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.531 ' HA ' HD11 ' A' ' 116' ' ' LEU . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.513 ' HB2' ' NE2' ' A' ' 123' ' ' HIS . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 127' ' ' ALA . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.647 ' C ' HG23 ' A' ' 161' ' ' VAL . 6.7 m80 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.606 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.712 ' CB ' HG11 ' A' ' 143' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 154' ' ' MET . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.765 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.606 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.647 HG23 ' C ' ' A' ' 135' ' ' HIS . 96.6 t -46.18 -68.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 166' ' ' ILE . 0.7 OUTLIER -110.23 -60.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 160' ' ' TRP . 68.1 p 49.72 39.49 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 12.2 m -109.32 -53.65 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -107.92 28.58 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -106.42 73.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 t -66.27 176.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.46 163.71 9.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 84.84 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.405 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.1 t -47.36 -53.37 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.799 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -165.57 167.32 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 t -84.19 -49.43 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 p -167.4 125.21 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.72 -126.41 0.84 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -94.7 164.91 12.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -52.11 139.47 23.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.19 117.65 2.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -132.02 158.98 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.497 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 118' ' ' LEU . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.702 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 124' ' ' LEU . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 114' ' ' VAL . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.702 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.63 HG22 HD23 ' A' ' 111' ' ' LEU . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.584 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.786 HG21 ' CD2' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.524 ' H ' HG23 ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 138' ' ' VAL . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.584 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -37.17 -32.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 160' ' ' TRP . 35.5 m-20 -150.26 106.57 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.597 ' HA ' HD11 ' A' ' 166' ' ' ILE . 13.3 m -106.53 86.32 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.4 t -112.33 84.88 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.1 tttp 61.32 45.53 8.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 163' ' ' SER . 69.6 mt -60.5 123.85 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 65.2 p -126.84 172.15 10.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.92 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.68 146.09 59.63 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.0 m -51.01 -39.67 56.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.8 t -68.23 124.82 24.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -90.18 85.84 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.824 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -89.21 123.81 33.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.57 89.83 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.521 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -98.46 167.66 10.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.893 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.8 p -116.23 110.91 19.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.03 149.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -133.46 150.36 51.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' OE2' ' A' ' 155' ' ' GLU . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.832 HD21 ' C ' ' A' ' 123' ' ' HIS . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.664 ' HB2' HD23 ' A' ' 115' ' ' LEU . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.832 ' C ' HD21 ' A' ' 116' ' ' LEU . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 124' ' ' LEU . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.655 HG22 HD23 ' A' ' 111' ' ' LEU . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.567 ' C ' HG23 ' A' ' 161' ' ' VAL . 7.6 m80 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.752 HG22 ' CE3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 145' ' ' ASP . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' H ' HG12 ' A' ' 143' ' ' VAL . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.482 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 154' ' ' MET . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.771 ' CB ' HG13 ' A' ' 150' ' ' VAL . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' HG12 ' A' ' 150' ' ' VAL . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.752 ' CE3' HG22 ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 135' ' ' HIS . 74.7 t -53.77 -56.18 10.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -121.86 -54.39 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 t 62.41 46.85 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.3 t -105.24 -45.42 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -128.54 37.04 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.63 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.2 pp -91.12 167.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 p -105.32 119.91 40.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -164.06 -156.3 8.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 2.82 3.2 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.624 2.216 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -40.14 -42.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 71.8 m -141.0 150.16 42.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.5 p -100.14 158.35 15.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.0 m -143.38 150.2 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.66 -46.63 1.02 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -79.99 170.41 16.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.841 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 m -127.6 -65.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -124.98 146.25 16.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.533 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -133.02 154.99 50.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.509 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.444 HD21 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 128' ' ' VAL . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 127' ' ' ALA . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.739 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 148' ' ' PHE . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.582 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.495 ' CD2' HG21 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 154' ' ' MET . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' MET . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 150' ' ' VAL . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' VAL . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 155' ' ' GLU . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.739 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.45 -54.68 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -109.72 -32.09 7.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -87.67 38.26 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -71.73 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' ILE . 13.0 tptm -58.26 -48.41 80.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 165' ' ' LYS . 48.3 mm -35.2 -49.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.21 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.7 p -122.57 102.29 7.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 164.36 83.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -1.85 9.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.278 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 66.6 m -44.08 130.3 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.2 t -56.95 -57.22 13.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.519 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.2 p -101.62 89.89 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m -108.13 96.1 6.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.06 -53.54 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.41 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.7 p -51.35 -38.48 53.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.3 p -80.48 138.43 36.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.37 116.82 1.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -123.49 154.73 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.512 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.423 HG21 ' HB ' ' A' ' 150' ' ' VAL . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.625 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 123' ' ' HIS . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.625 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.487 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 128' ' ' VAL . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 127' ' ' ALA . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.567 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.674 HG22 ' CE3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.575 HG11 ' CG ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.443 ' C ' HG12 ' A' ' 131' ' ' VAL . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CG ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.767 HG13 ' CB ' ' A' ' 154' ' ' MET . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.767 ' CB ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 150' ' ' VAL . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' MET . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 134' ' ' GLY . 56.0 t -37.3 -48.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -131.62 111.49 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.3 p -103.7 51.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 t -88.88 -59.88 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -122.85 41.39 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.2 pp -86.61 160.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 53.4 p -73.69 100.37 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.47 147.21 4.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.85 -14.62 36.03 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.232 . . . . 0.0 112.272 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 p 52.7 41.46 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.5 t -87.57 112.93 22.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.487 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 124' ' ' LEU . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.656 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.446 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 146' ' ' PRO . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 127' ' ' ALA . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.601 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.579 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.431 HG21 ' HE2' ' A' ' 148' ' ' PHE . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.904 HG21 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.904 ' CD2' HG21 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 154' ' ' MET . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.52 ' H ' HG23 ' A' ' 151' ' ' THR . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.579 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 134' ' ' GLY . 67.8 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.605 HG13 ' OE1' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.429 HD21 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.701 ' CB ' HD23 ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.867 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 127' ' ' ALA . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.44 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.0 m-70 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.704 HG22 ' CE3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.498 ' HB3' HG22 ' A' ' 161' ' ' VAL . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 140' ' ' PRO . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 139' ' ' GLY . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.577 HG21 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.606 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.477 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 138' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.605 ' OE1' HG13 ' A' ' 114' ' ' VAL . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.704 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.522 HG23 ' CA ' ' A' ' 136' ' ' VAL . 87.2 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' A' ' 124' ' ' LEU . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.687 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' A' ' 116' ' ' LEU . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 124' ' ' LEU . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.412 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 30.1 m-70 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.849 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.592 HG12 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.685 ' CD2' HG21 ' A' ' 143' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.619 ' H ' HG23 ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.433 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 155' ' ' GLU . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.849 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 118' ' ' LEU . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD11 ' HA ' ' A' ' 124' ' ' LEU . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.541 HD12 HG12 ' A' ' 114' ' ' VAL . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.724 ' HB2' HD23 ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.491 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.583 ' HA ' HD11 ' A' ' 116' ' ' LEU . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 124' ' ' LEU . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 127' ' ' ALA . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.533 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG22 ' CE3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.413 ' NH2' HG21 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.788 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.643 HG11 ' CG ' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 143' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.788 ' HE2' HG21 ' A' ' 138' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 150' ' ' VAL . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.413 HG21 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.77 ' CE3' HG22 ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' A' ' 124' ' ' LEU . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.64 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.501 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 128' ' ' VAL . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.905 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 124' ' ' LEU . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 127' ' ' ALA . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.526 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.866 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.732 HG21 ' HE2' ' A' ' 148' ' ' PHE . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.508 ' H ' HG12 ' A' ' 143' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.732 ' HE2' HG21 ' A' ' 138' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.588 ' HB3' HG13 ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.866 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 134' ' ' GLY . 24.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.859 HG11 ' OE1' ' A' ' 155' ' ' GLU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.649 HD23 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.649 ' CB ' HD23 ' A' ' 115' ' ' LEU . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.61 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.77 ' HA ' HD11 ' A' ' 116' ' ' LEU . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 124' ' ' LEU . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 127' ' ' ALA . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 33.1 m-70 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.797 HG22 ' CE3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG21 ' CE2' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 150' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 148' ' ' PHE . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.585 ' HB3' HG12 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.859 ' OE1' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.797 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 118' ' ' LEU . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 124' ' ' LEU . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 114' ' ' VAL . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.689 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.486 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' A' ' 116' ' ' LEU . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 146' ' ' PRO . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 127' ' ' ALA . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 145' ' ' ASP . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HG3' HG13 ' A' ' 128' ' ' VAL . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.537 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.514 ' HB3' HG13 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.44 HG13 ' OE1' ' A' ' 155' ' ' GLU . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.669 ' CB ' HD23 ' A' ' 115' ' ' LEU . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 128' ' ' VAL . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 127' ' ' ALA . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.508 ' C ' HG23 ' A' ' 161' ' ' VAL . 31.1 m-70 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.749 HG22 ' CE3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.761 HG21 ' CD2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.642 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.525 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 154' ' ' MET . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.7 ' HG2' HG13 ' A' ' 150' ' ' VAL . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 114' ' ' VAL . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.749 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 135' ' ' HIS . 85.6 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 118' ' ' LEU . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.921 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 114' ' ' VAL . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.626 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.723 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.921 ' HA ' HD11 ' A' ' 116' ' ' LEU . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 123' ' ' HIS . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 124' ' ' LEU . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.535 ' HB1' HE21 ' A' ' 133' ' ' GLN . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 127' ' ' ALA . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.535 HE21 ' HB1' ' A' ' 129' ' ' ALA . 59.1 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 148' ' ' PHE . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' C ' HG11 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 150' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 154' ' ' MET . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.45 ' H ' HG23 ' A' ' 151' ' ' THR . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 155' ' ' GLU . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.504 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.513 HD21 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.622 ' CB ' HD23 ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 128' ' ' VAL . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 124' ' ' LEU . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 127' ' ' ALA . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.546 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.43 HG21 ' CE2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.647 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.552 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD21 ' C ' ' A' ' 123' ' ' HIS . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.641 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 116' ' ' LEU . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 146' ' ' PRO . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 127' ' ' ALA . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.015 HG22 ' CE3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' A' ' 148' ' ' PHE . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 131' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 148' ' ' PHE . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 158' ' ' VAL . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 155' ' ' GLU . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 1.015 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.717 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 123' ' ' HIS . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.717 ' CB ' HD23 ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.57 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 128' ' ' VAL . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 124' ' ' LEU . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 127' ' ' ALA . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.658 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.41 ' C ' HG23 ' A' ' 161' ' ' VAL . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.679 HG22 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.599 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.87 HG21 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.87 ' CD2' HG21 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 154' ' ' MET . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 154' ' ' MET . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.542 ' CB ' HG13 ' A' ' 150' ' ' VAL . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 134' ' ' GLY . 87.5 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.494 HH21 HG22 ' A' ' 113' ' ' THR . 6.9 ptm180 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.667 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.494 HG22 HH21 ' A' ' 109' ' ' ARG . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 118' ' ' LEU . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.82 HD21 ' C ' ' A' ' 123' ' ' HIS . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 114' ' ' VAL . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.756 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.82 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.753 ' O ' HG23 ' A' ' 128' ' ' VAL . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.667 HG22 HD23 ' A' ' 111' ' ' LEU . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.796 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 161' ' ' VAL . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.64 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' C ' HG11 ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 138' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.796 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 137' ' ' ARG . 62.4 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 155' ' ' GLU . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.693 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.693 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.506 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 116' ' ' LEU . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.783 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.463 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.624 ' HB3' HG13 ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 158' ' ' VAL . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 155' ' ' GLU . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.783 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.515 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 110' ' ' ARG . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 124' ' ' LEU . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 114' ' ' VAL . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.631 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 128' ' ' VAL . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.864 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 124' ' ' LEU . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.706 HG22 ' CE3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.502 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.603 HG11 ' CB ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.534 ' C ' HG11 ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.603 ' CB ' HG11 ' A' ' 143' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.478 HG22 ' HE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 154' ' ' MET . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.687 ' H ' HG23 ' A' ' 151' ' ' THR . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 134' ' ' GLY . 78.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.51 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' OE2' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.574 HD23 ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.546 HD21 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.574 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.546 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.531 ' HA ' HD11 ' A' ' 116' ' ' LEU . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.513 ' HB2' ' NE2' ' A' ' 123' ' ' HIS . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 127' ' ' ALA . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.647 ' C ' HG23 ' A' ' 161' ' ' VAL . 22.2 m-70 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.606 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.712 ' CB ' HG11 ' A' ' 143' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 154' ' ' MET . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.765 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.606 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.647 HG23 ' C ' ' A' ' 135' ' ' HIS . 96.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.497 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 118' ' ' LEU . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.702 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 124' ' ' LEU . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 114' ' ' VAL . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.702 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.63 HG22 HD23 ' A' ' 111' ' ' LEU . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.584 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.786 HG21 ' CD2' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.524 ' H ' HG23 ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 138' ' ' VAL . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.584 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' OE2' ' A' ' 155' ' ' GLU . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.832 HD21 ' C ' ' A' ' 123' ' ' HIS . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.664 ' HB2' HD23 ' A' ' 115' ' ' LEU . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.832 ' C ' HD21 ' A' ' 116' ' ' LEU . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 124' ' ' LEU . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.655 HG22 HD23 ' A' ' 111' ' ' LEU . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.567 ' C ' HG23 ' A' ' 161' ' ' VAL . 24.2 m-70 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.752 HG22 ' CE3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 145' ' ' ASP . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' H ' HG12 ' A' ' 143' ' ' VAL . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.482 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 154' ' ' MET . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.771 ' CB ' HG13 ' A' ' 150' ' ' VAL . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' HG12 ' A' ' 150' ' ' VAL . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.752 ' CE3' HG22 ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 135' ' ' HIS . 74.7 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.509 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.444 HD21 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 128' ' ' VAL . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 127' ' ' ALA . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.739 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 148' ' ' PHE . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.582 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.495 ' CD2' HG21 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 154' ' ' MET . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' MET . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 150' ' ' VAL . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' VAL . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 155' ' ' GLU . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.739 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.512 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.423 HG21 ' HB ' ' A' ' 150' ' ' VAL . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.625 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 123' ' ' HIS . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.625 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 128' ' ' VAL . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 127' ' ' ALA . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.567 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.9 m-70 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.674 HG22 ' CE3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.575 HG11 ' CG ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.443 ' C ' HG12 ' A' ' 131' ' ' VAL . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CG ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.767 HG13 ' CB ' ' A' ' 154' ' ' MET . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.767 ' CB ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 150' ' ' VAL . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' MET . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 134' ' ' GLY . 56.0 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -121.69 170.3 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.859 0.361 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 t -86.12 118.91 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.04 -127.01 0.89 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.46 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -139.64 121.44 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.3 t -106.45 92.77 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.807 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.47 158.64 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.12 159.23 42.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.334 . . . . 0.0 110.847 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.487 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -61.84 140.4 58.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -55.55 -41.51 91.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.29 -42.41 67.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.655 2.236 . . . . 0.0 112.38 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 54.7 m -69.38 -44.09 72.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.099 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.88 -34.97 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.2 mt -68.78 -45.55 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 124' ' ' LEU . 68.3 mt -60.86 -40.93 94.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -66.73 -39.77 88.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.72 19.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 48.73 29.43 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.656 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.3 mmm -81.41 -30.41 33.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.37 172.24 8.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -87.48 -65.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.446 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.3 p80 -125.82 170.57 11.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.5 tp -52.93 -45.49 67.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -62.54 -35.95 81.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.33 -46.17 74.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.48 -42.83 95.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 146' ' ' PRO . 98.4 t -63.99 -46.43 93.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.198 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.15 95.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 21.4 m-85 -58.63 -44.14 89.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 127' ' ' ALA . 20.4 t -62.17 -38.64 81.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.92 -33.01 73.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.14 13.29 9.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.601 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 54.54 46.44 73.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.51 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -95.24 -27.67 15.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.579 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 24.0 t -116.37 140.37 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -131.91 158.34 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.431 HG21 ' HE2' ' A' ' 148' ' ' PHE . 58.5 t -120.01 111.15 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.45 -148.86 25.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 3.38 2.78 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.47 125.83 47.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.97 123.53 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.904 HG21 ' CD2' ' A' ' 148' ' ' PHE . 41.9 t -98.1 138.1 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.114 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -112.03 -22.48 11.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -101.63 138.43 19.85 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.733 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.595 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.0 Cg_endo -69.83 -31.55 19.99 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.256 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.33 -8.75 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.904 ' CD2' HG21 ' A' ' 143' ' ' VAL . 66.0 t80 -55.85 125.97 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.47 138.31 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 154' ' ' MET . 96.5 t -127.26 143.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -100.08 150.39 22.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -38.38 -40.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -62.5 -44.75 95.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.52 ' H ' HG23 ' A' ' 151' ' ' THR . 7.9 mmm -73.33 -31.26 63.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -46.75 -42.86 17.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.865 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.37 -22.71 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -93.12 33.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.63 121.52 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.1 t -139.5 158.07 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.579 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.8 m95 -84.02 131.99 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 134' ' ' GLY . 67.8 t -41.43 -51.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.89 98.78 4.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.6 p -102.61 34.01 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 t -60.22 -52.07 66.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.18 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 mm -39.07 130.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 77.7 p -83.11 168.49 16.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.21 81.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -11.18 30.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.663 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.3 m -83.83 150.98 25.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.824 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.7 p -137.93 135.76 36.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -88.24 143.12 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 t -135.64 151.34 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.29 97.26 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 p -43.33 -53.27 5.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.954 0.407 . . . . 0.0 110.906 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.8 p 45.9 39.24 5.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.93 111.69 0.49 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.528 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -120.86 144.1 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.8 mtm180 -60.82 142.66 55.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -54.77 -42.15 93.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.554 0.692 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -53.55 -42.46 65.64 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.746 2.297 . . . . 0.0 112.38 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.9 m -69.4 -44.09 72.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.605 HG13 ' OE1' ' A' ' 155' ' ' GLU . 52.5 t -62.0 -35.05 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.1 mt -69.11 -46.97 66.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD21 ' C ' ' A' ' 123' ' ' HIS . 76.4 mt -62.13 -38.58 89.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.4 tmtp? -71.45 -41.15 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.81 10.46 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 55.12 25.63 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.701 ' CB ' HD23 ' A' ' 115' ' ' LEU . 87.2 mtp -83.31 -35.29 25.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.28 165.9 11.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.5 -70.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.0 p80 -130.4 175.79 8.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.867 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.4 tp -53.95 -44.11 70.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -37.39 87.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.29 -48.98 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.31 -42.81 99.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 124' ' ' LEU . 91.8 t -63.21 -44.92 99.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.04 90.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.2 m-85 -58.36 -41.11 83.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 127' ' ' ALA . 94.9 t -62.75 -50.96 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.183 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.33 -18.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.44 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 23.3 mt-30 -93.49 16.21 14.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 48.76 27.62 6.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.0 m-70 -81.22 -13.48 58.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.341 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.704 HG22 ' CE3' ' A' ' 160' ' ' TRP . 13.7 t -132.51 140.27 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.498 ' HB3' HG22 ' A' ' 161' ' ' VAL . 11.0 ptt180 -127.15 154.25 45.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 148' ' ' PHE . 90.0 t -118.62 112.46 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 140' ' ' PRO . . . 55.08 -148.94 23.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 139' ' ' GLY . 54.0 Cg_endo -69.74 3.42 2.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -120.47 134.02 55.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.856 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.3 t -91.01 111.31 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.577 HG21 ' CD2' ' A' ' 148' ' ' PHE . 53.4 t -83.46 131.08 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 p -123.74 21.4 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.606 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.8 t70 -146.11 139.43 14.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.59 0.71 . . . . 0.0 110.829 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.477 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.75 -31.1 21.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.758 2.305 . . . . 0.0 112.305 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.18 -7.94 4.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 138' ' ' VAL . 65.7 t80 -55.93 121.71 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 47.3 mt -84.64 139.05 32.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.9 t -132.04 134.84 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' GLU . 14.3 t -105.57 176.13 5.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -52.44 -50.48 62.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.4 t -64.62 -19.45 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.566 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.7 ttm -99.95 -17.16 17.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.605 ' OE1' HG13 ' A' ' 114' ' ' VAL . 15.5 mm-40 -61.03 -26.58 67.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.24 -15.83 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -88.13 21.83 2.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.13 121.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.7 t -141.22 157.95 44.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.704 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.5 m95 -84.0 135.23 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.522 HG23 ' CA ' ' A' ' 136' ' ' VAL . 87.2 t -64.72 -40.73 90.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -134.96 83.91 2.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.855 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.3 t -84.65 92.31 8.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.1 p -106.28 84.41 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 58.03 40.72 25.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.94 129.58 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -46.76 -46.91 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 39.94 -160.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 150.44 68.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.7 t -160.22 155.46 24.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.9 t 48.62 41.54 17.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.831 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.545 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -115.43 84.53 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -110.46 163.44 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.52 62.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.514 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.8 t -139.55 111.17 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.4 t -97.97 -51.73 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.14 148.86 35.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NH2' ' OE2' ' A' ' 155' ' ' GLU . 55.7 mtm180 -136.96 158.72 43.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -60.95 141.01 57.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.5 tp -55.58 -41.63 91.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.1 Cg_exo -53.47 -42.61 64.31 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.723 2.282 . . . . 0.0 112.368 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 91.7 m -69.39 -44.11 72.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.55 -36.8 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.7 mt -67.55 -46.97 71.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' A' ' 124' ' ' LEU . 82.6 mt -61.06 -39.21 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 8.9 tmtt? -72.69 -36.5 67.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.0 mt -82.68 19.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 47.52 27.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.687 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.4 mtp -89.49 -19.97 24.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.74 157.11 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -78.52 -58.18 3.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -137.92 170.59 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HA ' HD11 ' A' ' 116' ' ' LEU . 66.6 tp -52.96 -48.49 67.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 7.1 tt0 -59.39 -36.82 76.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -68.22 -47.63 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.082 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.2 -42.92 99.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 124' ' ' LEU . 86.4 t -63.81 -46.91 93.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.164 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.18 98.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.067 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.4 m-85 -59.11 -44.08 91.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.1 t -60.98 -51.72 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.88 -32.31 72.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.412 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.8 mt-30 -83.83 19.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 51.19 5.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 30.1 m-70 -101.01 -25.49 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.849 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.8 t -118.9 140.7 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -130.54 155.47 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.592 HG12 ' CE ' ' A' ' 154' ' ' MET . 53.8 t -119.26 112.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.18 -148.92 23.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 3.48 2.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -121.0 127.8 52.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.04 116.44 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 148' ' ' PHE . 86.9 t -88.84 134.13 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 p -118.14 -3.24 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' C ' HG11 ' A' ' 131' ' ' VAL . 6.1 t70 -119.42 136.42 24.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 0.0 110.835 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.71 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.365 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.15 -6.32 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.685 ' CD2' HG21 ' A' ' 143' ' ' VAL . 81.0 t80 -58.38 127.32 31.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.57 139.03 30.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.2 t -130.09 138.38 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 154' ' ' MET . 11.4 t -103.27 150.33 23.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 151' ' ' THR . 2.3 tmm_? -36.17 -45.1 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 -41.97 95.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.619 ' H ' HG23 ' A' ' 151' ' ' THR . 7.2 tpt -76.6 -18.98 58.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' OE2' ' NH2' ' A' ' 109' ' ' ARG . 63.3 mt-10 -62.79 -39.2 93.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -67.61 -26.35 66.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 48.4 m-85 -91.67 34.49 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 155' ' ' GLU . 93.6 t -105.1 122.15 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.096 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 t -141.57 157.77 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.849 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.9 m95 -84.07 152.08 24.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.0 t -66.72 -62.99 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 162' ' ' ASP . 3.8 p-10 -123.5 106.38 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.418 ' HA ' ' CG1' ' A' ' 166' ' ' ILE . 79.2 p -108.06 47.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.5 t -104.75 -51.67 3.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 166' ' ' ILE . 34.5 tttt -96.72 -49.42 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.7 pp -36.07 145.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.8 m -69.79 162.99 26.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.19 75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.61 18.64 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 t -96.17 149.38 21.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.8 m 53.93 43.74 30.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.879 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.1 p -38.88 -50.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.8 p -40.38 114.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.13 110.49 2.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.8 p -98.94 108.1 20.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.9 m -57.25 -44.92 84.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.81 148.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -124.44 147.69 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.7 mtm180 -61.03 144.24 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -58.25 -41.61 90.46 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.62 65.72 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.33 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.7 m -69.49 -44.09 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 118' ' ' LEU . 95.4 t -60.29 -35.15 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.724 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.1 mt -70.23 -47.07 63.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD11 ' HA ' ' A' ' 124' ' ' LEU . 94.4 mt -61.48 -38.83 88.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.5 tmtp? -73.86 -37.32 64.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.541 HD12 HG12 ' A' ' 114' ' ' VAL . 76.5 mt -80.45 13.46 2.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.1 mmt-85 50.59 32.21 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.724 ' HB2' HD23 ' A' ' 115' ' ' LEU . 92.4 mtp -93.63 -21.79 19.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.22 166.98 13.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -84.61 -61.12 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.491 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 4.4 p80 -138.09 174.48 10.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.583 ' HA ' HD11 ' A' ' 116' ' ' LEU . 46.7 tp -53.03 -47.3 68.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.99 -39.45 89.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.68 -47.74 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.53 -42.85 99.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 124' ' ' LEU . 55.4 t -64.59 -49.04 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.518 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.7 m-85 -59.63 -43.97 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 127' ' ' ALA . 42.8 t -60.41 -52.08 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.2 -25.5 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 29.4 mt-30 -83.25 15.86 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.38 29.11 16.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.531 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.533 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 35.6 m-70 -84.2 -18.42 36.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG22 ' CE3' ' A' ' 160' ' ' TRP . 58.6 t -125.55 138.26 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.413 ' NH2' HG21 ' A' ' 159' ' ' THR . 31.4 ptt85 -128.87 157.82 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.788 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.0 t -120.09 111.6 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.84 -148.93 22.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 3.38 2.8 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.4 128.62 53.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.06 114.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.643 HG11 ' CG ' ' A' ' 148' ' ' PHE . 36.2 t -95.83 134.39 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.2 p -125.18 32.75 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 143' ' ' VAL . 7.1 t70 -144.81 135.7 12.31 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.522 0.677 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.0 Cg_endo -69.84 -25.64 28.01 Favored 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.67 2.246 . . . . 0.0 112.311 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.22 3.36 5.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.788 ' HE2' HG21 ' A' ' 138' ' ' VAL . 47.7 t80 -66.95 123.12 19.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -87.55 137.74 32.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 154' ' ' MET . 97.8 t -131.66 129.67 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 154' ' ' MET . 67.7 p -84.06 152.59 24.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -43.86 -37.95 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.79 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 -28.78 52.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.664 ' HB3' HG13 ' A' ' 150' ' ' VAL . 7.0 tpt -79.93 -27.66 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -55.11 -27.38 44.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.33 -25.71 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -91.78 34.48 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.54 120.95 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.413 HG21 ' NH2' ' A' ' 137' ' ' ARG . 5.1 t -141.96 157.99 44.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.77 ' CE3' HG22 ' A' ' 136' ' ' VAL . 91.4 m95 -84.99 134.66 34.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -55.9 -52.48 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.6 93.61 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.481 ' HA ' HD11 ' A' ' 166' ' ' ILE . 94.2 p -113.88 63.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.3 t -107.32 -43.18 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.795 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -129.77 64.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 163' ' ' SER . 74.9 mt -94.51 -54.24 7.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.2 p -125.62 146.2 49.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.29 149.66 49.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -17.17 38.23 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.271 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.0 p -141.77 142.11 33.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -39.0 137.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -87.25 90.46 8.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.6 p -125.16 124.83 42.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.7 -151.83 8.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.7 t -118.76 -56.59 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.2 p -136.3 111.59 9.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -118.48 157.7 15.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 mmt-85 -129.75 144.39 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.7 mtm180 -60.81 142.49 56.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -55.71 -41.73 92.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.593 0.711 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.6 Cg_exo -54.24 -42.57 66.25 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.42 -44.16 71.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 118' ' ' LEU . 85.8 t -64.04 -37.42 79.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.64 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.5 mt -66.77 -43.04 85.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' A' ' 124' ' ' LEU . 22.8 mt -65.17 -35.8 82.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 3.9 tmtm? -81.17 -33.64 32.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.589 HD12 HG12 ' A' ' 114' ' ' VAL . 22.8 mt -80.15 12.96 2.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 55.29 26.92 9.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.64 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.7 mmm -86.95 -36.98 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -116.05 171.01 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -90.52 -68.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.501 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.5 p80 -123.42 169.6 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 128' ' ' VAL . 54.5 tp -52.96 -42.86 65.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 15.8 tt0 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.45 -48.74 54.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.905 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.85 -42.97 99.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 124' ' ' LEU . 85.1 t -66.6 -46.0 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.94 95.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.7 m-85 -58.36 -43.82 88.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 127' ' ' ALA . 47.4 t -58.9 -51.46 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.07 -27.53 67.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -86.97 23.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.526 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 42.38 53.7 4.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -105.08 -25.81 12.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.824 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.866 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.5 t -121.9 139.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -127.19 156.36 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.732 HG21 ' HE2' ' A' ' 148' ' ' PHE . 84.5 t -119.16 112.58 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.11 24.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.507 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.5 2.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.369 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 26.6 m-20 -120.94 132.47 54.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.2 t -90.69 111.5 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 148' ' ' PHE . 68.8 t -82.79 130.71 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 p -122.36 28.54 7.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.508 ' H ' HG12 ' A' ' 143' ' ' VAL . 2.9 t70 -150.02 136.05 10.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.617 0.722 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.89 11.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 0.0 112.38 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.63 -10.97 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.732 ' HE2' HG21 ' A' ' 138' ' ' VAL . 37.4 t80 -53.76 126.07 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -88.37 135.05 33.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 148' ' ' PHE . 77.8 t -131.99 142.04 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.3 t -114.02 166.97 11.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -42.43 -62.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -51.35 -25.84 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.588 ' HB3' HG13 ' A' ' 150' ' ' VAL . 4.6 tpt -91.14 -23.59 20.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -62.77 -35.22 79.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.74 -13.56 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.16 32.84 3.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.9 t -102.61 121.28 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -141.96 158.01 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.866 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.6 m95 -83.99 145.12 28.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 134' ' ' GLY . 24.8 t -41.37 -42.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -112.7 -44.31 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.82 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.8 m 60.09 40.51 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.5 t -106.35 -53.85 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.0 OUTLIER -76.03 -55.79 5.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.694 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.9 pp -33.95 140.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.8 m -127.77 173.99 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.97 -158.2 10.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.38 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.1 t -50.61 -59.22 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.9 p -40.78 129.67 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -163.02 135.96 5.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.843 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -135.43 120.68 18.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.4 67.82 3.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 156.46 37.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 110.901 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 m -104.17 44.38 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.91 146.49 6.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -136.58 151.62 49.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.376 . . . . 0.0 110.792 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.1 mtm-85 -60.83 140.13 57.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.0 tp -55.07 -41.58 91.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.2 Cg_exo -53.93 -42.52 66.01 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 0.0 112.267 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.3 m -69.24 -44.1 72.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.859 HG11 ' OE1' ' A' ' 155' ' ' GLU . 95.7 t -64.12 -35.33 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.649 HD23 ' CB ' ' A' ' 120' ' ' MET . 7.9 mt -67.16 -46.49 73.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.9 mt -65.7 -40.62 92.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 9.1 tmtt? -71.44 -35.42 70.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 114' ' ' VAL . 56.9 mt -83.58 21.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 48.8 25.11 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.649 ' CB ' HD23 ' A' ' 115' ' ' LEU . 45.3 mmm -84.48 -29.37 26.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.56 -176.0 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -100.49 -74.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.61 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.2 p80 -120.03 172.36 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.77 ' HA ' HD11 ' A' ' 116' ' ' LEU . 52.8 tp -53.34 -47.77 69.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -60.1 -37.61 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.84 -46.15 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -43.05 88.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 124' ' ' LEU . 96.5 t -64.24 -44.5 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.124 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.31 83.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.7 -43.68 92.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 127' ' ' ALA . 98.5 t -63.15 -45.59 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.86 -25.8 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.6 mt-30 -89.72 24.23 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.934 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 41.1 53.27 3.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 33.1 m-70 -107.63 -28.75 9.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.797 HG22 ' CE3' ' A' ' 160' ' ' TRP . 47.5 t -115.93 131.42 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -119.0 150.98 39.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.502 ' CG1' ' SD ' ' A' ' 154' ' ' MET . 93.8 t -112.18 110.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 56.59 -147.85 31.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 138' ' ' VAL . 15.8 m-20 -123.34 135.15 54.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.0 109.93 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG21 ' CE2' ' A' ' 148' ' ' PHE . 96.9 t -87.44 131.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -113.55 -12.43 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -103.63 134.52 19.7 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.614 0.721 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -42.39 3.4 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.83 -18.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.801 ' CE2' HG22 ' A' ' 150' ' ' VAL . 78.4 t80 -45.95 126.7 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.1 mt -93.14 135.86 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.801 HG22 ' CE2' ' A' ' 148' ' ' PHE . 4.1 t -132.05 138.68 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 152' ' ' ARG . 74.9 p -92.38 146.18 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 151' ' ' THR . 12.0 tpt180 -34.07 -70.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 t -43.89 -36.9 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.585 ' HB3' HG12 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -73.34 -36.7 66.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.859 ' OE1' HG11 ' A' ' 114' ' ' VAL . 43.3 mm-40 -47.04 -39.49 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -55.67 -32.88 63.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -86.49 33.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.21 120.92 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 t -142.02 158.05 44.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.797 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.0 m95 -83.96 148.14 27.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.43 -56.73 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.86 94.08 4.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.7 t -109.49 81.69 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.6 p -100.89 87.33 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 59.87 40.48 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp -88.07 162.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.1 t -80.69 104.23 11.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.13 -172.91 13.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 99.98 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.0 m -52.96 159.49 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -70.37 127.34 32.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.0 p -95.52 89.72 5.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 m -53.1 128.02 26.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -53.46 103.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 m -133.25 84.14 2.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.9 m -43.82 124.95 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -52.82 151.22 8.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.8 mtt-85 -137.09 155.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 110.858 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.8 mtm-85 -60.99 143.95 54.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -57.03 -41.79 93.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.8 Cg_exo -54.17 -42.37 67.87 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.7 m -69.32 -44.15 72.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 118' ' ' LEU . 99.0 t -62.71 -34.97 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.171 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 120' ' ' MET . 9.6 mt -69.61 -43.45 72.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.7 HD11 ' HA ' ' A' ' 124' ' ' LEU . 98.7 mt -65.43 -36.74 84.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -77.07 -34.82 56.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 114' ' ' VAL . 21.0 mt -81.55 13.02 3.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 54.33 28.44 9.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.689 ' CB ' HD23 ' A' ' 115' ' ' LEU . 35.4 mmm -84.68 -34.67 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.6 173.47 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.078 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -90.76 -66.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.486 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.4 p80 -123.59 170.05 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' A' ' 116' ' ' LEU . 23.3 tp -53.95 -48.03 70.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.5 tp60 -59.0 -35.98 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.98 -43.27 71.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -67.26 -43.0 82.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 146' ' ' PRO . 75.9 t -64.22 -45.02 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.96 96.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.8 m-85 -59.32 -42.94 92.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 127' ' ' ALA . 85.2 t -61.33 -53.75 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -66.43 -24.39 66.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -85.34 10.99 11.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 54.77 32.1 54.58 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -86.44 -20.24 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 160' ' ' TRP . 31.3 t -125.69 142.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -132.29 157.34 44.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.89 112.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.86 -149.12 21.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 3.47 2.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -120.17 130.19 54.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.72 114.29 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 145' ' ' ASP . 48.8 t -87.96 132.82 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.1 p -125.75 28.58 6.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t70 -148.4 133.82 9.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.73 . . . . 0.0 110.89 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HG3' HG13 ' A' ' 128' ' ' VAL . 54.4 Cg_endo -69.72 -19.38 36.37 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.344 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.537 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -77.11 4.51 10.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 143' ' ' VAL . 69.6 t80 -73.38 125.35 27.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.52 139.09 31.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' MET . 55.6 t -125.76 142.99 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -105.32 165.46 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -51.69 -41.06 61.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -68.03 -20.86 65.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.514 ' HB3' HG13 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -96.0 -23.42 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -54.46 -22.46 12.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.75 -17.66 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -94.81 27.52 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.93 121.53 51.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.98 158.05 44.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 136' ' ' VAL . 96.5 m95 -84.04 133.35 34.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.87 -54.6 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.84 -46.56 5.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' HD13 ' A' ' 166' ' ' ILE . 2.3 t 62.14 31.01 17.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.5 p -50.6 -74.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -70.59 -39.47 73.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 166' ' ' ILE . 4.1 mp -45.44 119.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.7 m -39.07 -58.68 1.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.2 173.53 14.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.57 2.42 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.767 2.311 . . . . 0.0 112.378 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 m -63.46 -60.53 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.782 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.2 m -59.28 117.34 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.453 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -78.61 129.47 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.832 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -90.24 82.88 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.13 69.68 0.5 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.8 m -65.16 93.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.4 m -40.87 -63.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.14 166.7 12.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -126.75 147.37 49.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 4.0 mtt180 -60.72 147.2 43.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -56.73 -42.41 96.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.607 0.718 . . . . 0.0 110.833 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 59.8 Cg_exo -53.06 -42.61 63.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.282 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.4 m -69.82 -43.02 72.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.44 HG13 ' OE1' ' A' ' 155' ' ' GLU . 74.2 t -59.87 -36.77 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.2 mt -69.77 -47.07 64.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 123' ' ' HIS . 13.3 mt -62.45 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -77.47 -37.9 50.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.25 17.78 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 48.6 27.37 1.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.669 ' CB ' HD23 ' A' ' 115' ' ' LEU . 88.6 mtp -86.58 -30.64 21.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.72 172.75 7.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -89.65 -70.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.405 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.4 p80 -125.55 176.12 7.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.691 ' O ' HG23 ' A' ' 128' ' ' VAL . 47.2 tp -56.79 -45.33 82.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -62.12 -36.48 81.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.2 -45.35 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.053 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.87 -42.98 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.7 t -62.91 -48.89 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.61 92.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.2 m-85 -59.37 -42.3 91.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 127' ' ' ALA . 41.2 t -60.28 -50.39 80.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.61 -27.54 67.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 34.0 mt-30 -84.86 16.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 43.88 44.55 7.2 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.508 ' C ' HG23 ' A' ' 161' ' ' VAL . 31.1 m-70 -96.69 -20.86 17.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.749 HG22 ' CE3' ' A' ' 160' ' ' TRP . 11.0 t -123.84 142.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -131.88 157.81 43.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.6 t -119.98 111.09 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.177 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.46 -148.96 24.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 3.58 2.73 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.67 2.247 . . . . 0.0 112.368 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -121.09 130.0 53.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.02 120.05 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.761 HG21 ' CD2' ' A' ' 148' ' ' PHE . 79.7 t -95.81 127.59 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 p -113.42 8.22 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.172 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.642 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.3 t70 -130.58 139.66 36.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.655 0.74 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.525 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.81 -37.03 9.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.631 2.221 . . . . 0.0 112.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.42 -13.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 143' ' ' VAL . 73.7 t80 -51.92 124.44 12.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.64 139.18 30.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 154' ' ' MET . 39.7 t -127.34 132.04 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -96.3 163.72 12.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -46.62 -56.26 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.8 t -58.2 -16.67 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.7 ' HG2' HG13 ' A' ' 150' ' ' VAL . 24.4 ttm -101.33 -19.32 15.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 114' ' ' VAL . 14.9 mm-40 -55.03 -36.88 65.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.71 -20.97 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -83.31 20.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 81.7 t -95.34 121.38 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.3 158.08 44.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.749 ' CE3' HG22 ' A' ' 136' ' ' VAL . 79.0 m95 -84.09 133.34 34.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 135' ' ' HIS . 85.6 t -47.92 -39.96 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -137.85 107.45 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.3 p -124.85 76.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.6 m -100.17 88.39 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt 57.57 36.49 26.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.0 pp -87.24 -21.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.424 ' N ' HD12 ' A' ' 166' ' ' ILE . 23.1 t -94.36 94.23 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -60.66 -159.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.439 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -4.66 14.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.691 2.261 . . . . 0.0 112.304 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 t -47.42 134.22 11.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 77.1 p -59.42 106.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.0 t -104.56 127.49 52.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.375 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.9 m -91.75 112.08 23.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.46 171.67 41.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.477 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.8 t -114.6 -58.63 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -112.11 169.42 8.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.17 175.4 17.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mtp85 -126.18 158.49 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.498 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 6.0 mtm180 -60.77 144.25 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -57.21 -41.78 92.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.698 0.761 . . . . 0.0 110.974 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.5 Cg_exo -53.49 -42.75 63.26 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.705 2.27 . . . . 0.0 112.311 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -69.64 -44.08 71.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 118' ' ' LEU . 57.4 t -63.58 -36.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.064 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.6 mt -67.62 -44.94 76.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.921 HD11 ' HA ' ' A' ' 124' ' ' LEU . 80.1 mt -63.97 -35.06 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.9 tmtm? -76.25 -38.26 56.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 114' ' ' VAL . 93.4 mt -79.58 11.97 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 57.06 27.89 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.626 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -84.45 -28.0 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.47 180.0 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -93.03 -68.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.723 ' C ' HD21 ' A' ' 116' ' ' LEU . 3.6 p80 -126.91 174.43 8.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.921 ' HA ' HD11 ' A' ' 116' ' ' LEU . 54.9 tp -53.24 -43.51 67.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -64.53 -39.2 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 123' ' ' HIS . . . -66.86 -47.36 72.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -62.08 -42.88 99.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 124' ' ' LEU . 71.3 t -63.91 -45.98 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.535 ' HB1' HE21 ' A' ' 133' ' ' GLN . . . -60.74 -39.74 89.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -64.78 -39.37 93.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 127' ' ' ALA . 51.8 t -62.82 -51.59 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -68.78 -30.28 68.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.535 HE21 ' HB1' ' A' ' 129' ' ' ALA . 59.1 mt-30 -81.44 12.95 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.54 52.41 24.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -104.25 -25.07 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 8.1 t -121.83 138.19 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 161' ' ' VAL . 2.8 ptt-85 -127.15 157.54 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 148' ' ' PHE . 25.3 t -120.04 112.31 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.23 -149.13 23.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.64 2.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -120.85 129.97 53.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.3 t -90.92 109.95 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 148' ' ' PHE . 63.2 t -85.07 129.99 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.0 p -122.52 22.63 9.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' C ' HG11 ' A' ' 131' ' ' VAL . 9.7 t70 -138.36 132.36 16.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.577 0.703 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.35 30.02 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.384 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -73.34 3.77 5.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.546 ' CE2' HG22 ' A' ' 150' ' ' VAL . 40.2 t80 -70.02 125.26 26.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 mt -87.83 136.03 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 148' ' ' PHE . 61.0 t -132.0 138.66 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 154' ' ' MET . 14.7 t -103.58 163.72 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -51.63 -35.45 41.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 t -76.26 -22.62 54.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.45 ' H ' HG23 ' A' ' 151' ' ' THR . 6.2 tpt -94.63 -21.12 19.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 58.3 mt-10 -64.14 -34.52 78.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.7 -10.68 28.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -105.76 28.71 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 155' ' ' GLU . 85.9 t -95.74 123.68 48.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -142.02 158.08 44.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.512 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 97.8 m95 -83.83 135.36 34.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 20.4 t -41.43 -50.76 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -97.73 -51.77 3.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t 56.35 46.94 20.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.7 m -121.12 -45.97 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -102.21 40.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.916 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 166' ' ' ILE . 42.0 mm -81.69 54.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.7 t -67.9 103.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -144.5 144.8 13.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -23.12 31.45 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -39.06 152.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 t -123.94 145.57 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -52.07 -43.93 64.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 m -92.93 -46.53 7.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.31 -105.75 0.29 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.9 p -113.69 175.64 5.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -116.35 121.67 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.66 170.86 27.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -111.24 138.9 47.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.504 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 9.2 mtm180 -60.84 141.59 56.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.64 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.3 tp -54.59 -41.84 91.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 51.7 Cg_exo -55.1 -42.82 65.2 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.659 2.239 . . . . 0.0 112.353 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.7 m -69.45 -44.16 71.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.193 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.83 -34.86 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' CB ' ' A' ' 120' ' ' MET . 11.7 mt -67.46 -44.56 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD21 ' C ' ' A' ' 123' ' ' HIS . 89.7 mt -61.02 -42.85 99.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 117' ' ' LYS . 4.5 tmtm? -71.53 -34.27 69.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.9 mt -82.45 18.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 50.27 25.68 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.622 ' CB ' HD23 ' A' ' 115' ' ' LEU . 37.5 mmm -82.36 -31.67 29.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.45 169.32 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -88.16 -60.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.513 ' C ' HD21 ' A' ' 116' ' ' LEU . 6.7 p80 -129.9 170.57 13.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 128' ' ' VAL . 21.9 tp -53.13 -47.27 68.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 10.8 tp60 -58.88 -35.99 73.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.94 -45.32 64.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -64.56 -43.16 94.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 124' ' ' LEU . 88.1 t -65.22 -45.29 94.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.41 95.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 24.3 m-85 -60.3 -42.67 96.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 127' ' ' ALA . 49.0 t -59.29 -52.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.132 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.27 -24.59 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 39.5 mt-30 -84.37 11.99 7.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 49.07 41.9 30.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.499 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 27.2 m-70 -96.05 -26.79 15.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.546 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 25.7 t -115.66 133.47 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -122.81 154.02 38.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 141' ' ' ASP . 36.5 t -118.29 112.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.7 -148.91 26.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 3.6 2.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.723 2.282 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 21.9 m-20 -121.38 132.19 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -90.53 112.9 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.181 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.43 HG21 ' CE2' ' A' ' 148' ' ' PHE . 97.5 t -84.2 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -122.97 23.85 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.647 ' C ' HG11 ' A' ' 131' ' ' VAL . 4.8 t70 -145.34 136.2 12.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.552 ' HG3' HG13 ' A' ' 128' ' ' VAL . 53.6 Cg_endo -69.76 -35.22 13.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.38 -7.65 4.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.43 ' CE2' HG21 ' A' ' 143' ' ' VAL . 79.2 t80 -56.13 127.45 30.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.4 mt -85.17 138.94 32.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 148' ' ' PHE . 86.2 t -128.5 128.87 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.9 p -93.42 160.51 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -44.36 -54.48 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -22.47 66.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 3.7 tpt -89.43 -15.25 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -71.33 -21.9 61.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.33 -15.38 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -97.13 31.2 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.76 121.06 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -142.03 157.63 44.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 92.9 m95 -84.1 139.48 32.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.8 t -53.18 -51.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.157 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.03 107.75 13.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 166' ' ' ILE . 72.9 p -121.55 94.25 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -122.9 95.84 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? 52.82 45.28 29.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 163' ' ' SER . 75.4 mt -67.99 112.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.1 m -75.16 173.41 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.89 -161.98 19.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.463 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 117.72 5.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.748 2.299 . . . . 0.0 112.255 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.3 p -98.32 139.67 33.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.833 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.2 m -125.47 -52.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.413 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -115.97 169.98 8.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -117.04 100.85 8.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.34 -52.65 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.447 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -112.75 153.76 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -142.34 124.92 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.88 172.68 46.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -137.13 153.58 50.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtt85 -61.06 145.55 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.1 tp -59.22 -41.48 87.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.566 0.698 . . . . 0.0 110.966 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 52.2 Cg_exo -54.7 -42.48 68.08 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.636 2.224 . . . . 0.0 112.373 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 50.0 m -69.32 -44.2 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.62 -34.99 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.9 mt -70.16 -44.18 69.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD21 ' C ' ' A' ' 123' ' ' HIS . 78.7 mt -60.86 -44.48 96.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -71.51 -35.41 70.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.3 mt -80.19 13.27 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.953 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 51.78 24.94 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.641 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.4 mmm -80.16 -39.87 28.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 -177.39 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -96.81 -67.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.4 p80 -125.56 -177.65 3.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 116' ' ' LEU . 56.3 tp -61.95 -49.35 76.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.98 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.84 -36.4 74.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.68 64.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.169 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.054 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 146' ' ' PRO . 71.2 t -65.87 -45.23 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.96 96.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -58.98 -43.83 91.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 127' ' ' ALA . 87.2 t -64.92 -41.62 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.071 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.79 -36.47 82.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.16 20.7 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 44.48 49.17 8.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -96.23 -21.45 17.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.015 HG22 ' CE3' ' A' ' 160' ' ' TRP . 7.2 t -126.32 141.46 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -128.6 158.19 39.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' A' ' 148' ' ' PHE . 54.2 t -117.04 111.1 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.72 -148.56 26.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 3.39 2.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.51 133.35 55.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.1 127.76 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 148' ' ' PHE . 64.3 t -104.17 138.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 131' ' ' VAL . 2.0 p -121.79 -25.52 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -88.47 131.98 40.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.534 0.683 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.5 Cg_endo -69.7 -18.14 37.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.31 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.45 7.39 19.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 143' ' ' VAL . 65.1 t80 -68.38 121.32 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.37 138.93 31.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 148' ' ' PHE . 26.9 t -126.24 142.83 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.19 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 154' ' ' MET . 41.9 p -90.83 146.11 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -41.76 -24.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 151' ' ' THR . 7.7 t -77.69 -42.8 33.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 151' ' ' THR . 15.4 mmm -75.61 -28.26 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 158' ' ' VAL . 84.3 mt-10 -45.15 -39.41 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -74.84 -26.21 59.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 154' ' ' MET . 26.2 m-85 -86.52 27.02 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 155' ' ' GLU . 59.0 t -95.41 122.17 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.2 t -139.71 157.98 44.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 1.015 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -84.65 128.42 34.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.9 t -41.61 -69.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -127.44 92.69 3.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.1 p -120.12 36.14 4.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -66.52 -60.2 2.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.84 -33.09 68.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 24.4 mm -50.98 130.56 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.111 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 p 40.86 43.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -74.83 -169.29 23.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 170' ' ' SER . 53.9 Cg_endo -69.73 -9.37 25.94 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 169' ' ' PRO . 91.5 p -37.78 121.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -127.51 132.02 50.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 m -87.21 135.59 33.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.1 t -68.82 120.25 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 173.23 40.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.461 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.2 m -78.67 121.18 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 0.0 110.832 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -125.09 -47.61 1.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.07 137.26 2.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -136.73 156.21 48.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.495 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 0.9 OUTLIER -60.89 144.59 52.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.0 -41.84 93.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.657 0.742 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 54.0 Cg_exo -53.57 -42.6 64.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.6 m -69.35 -44.15 72.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.68 -34.88 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.717 HD23 ' CB ' ' A' ' 120' ' ' MET . 8.0 mt -69.0 -47.05 66.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD21 ' C ' ' A' ' 123' ' ' HIS . 84.6 mt -60.85 -34.98 75.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -78.49 -35.78 46.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.4 mt -83.37 21.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.5 mtm-85 45.78 29.3 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.717 ' CB ' HD23 ' A' ' 115' ' ' LEU . 86.3 mtp -92.28 -19.74 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.0 160.37 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.1 -60.53 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.57 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -134.37 169.99 16.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 128' ' ' VAL . 65.0 tp -53.14 -46.34 68.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.5 tt0 -59.41 -39.31 83.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.61 -45.98 73.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -66.03 -42.85 89.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 124' ' ' LEU . 98.4 t -62.89 -45.82 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 19.1 m-85 -58.14 -45.05 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 127' ' ' ALA . 43.8 t -60.19 -47.04 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.66 -26.93 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -85.05 9.96 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.658 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 52.23 42.33 55.6 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.471 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' C ' HG23 ' A' ' 161' ' ' VAL . 27.2 m-70 -98.88 -19.56 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.817 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.679 HG22 ' CE3' ' A' ' 160' ' ' TRP . 59.1 t -122.69 140.58 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -134.69 158.63 43.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.599 HG21 ' HE2' ' A' ' 148' ' ' PHE . 93.9 t -118.72 111.06 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.33 -148.82 24.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.55 2.7 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.19 128.81 52.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.3 t -91.09 131.02 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.177 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.87 HG21 ' CD2' ' A' ' 148' ' ' PHE . 91.0 t -105.81 132.13 53.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.1 p -115.36 -8.83 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -111.99 133.94 21.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -14.99 36.86 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.719 2.279 . . . . 0.0 112.317 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.99 7.73 10.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.87 ' CD2' HG21 ' A' ' 143' ' ' VAL . 42.9 t80 -71.68 128.46 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.85 139.01 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 154' ' ' MET . 58.4 t -131.48 141.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 154' ' ' MET . 17.6 p -103.57 155.19 18.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -42.62 -27.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -73.46 -39.87 64.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.542 ' CB ' HG13 ' A' ' 150' ' ' VAL . 7.9 mmm -83.56 -26.82 29.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -49.36 -34.07 15.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.926 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.26 -20.93 43.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.57 25.35 3.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 80.8 t -94.98 121.02 45.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.0 t -141.99 158.09 44.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 136' ' ' VAL . 76.5 m95 -83.97 138.27 33.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 134' ' ' GLY . 87.5 t -43.66 -25.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -147.52 108.67 4.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.11 89.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 42.1 t -118.93 94.06 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 38.2 mttm 54.19 35.34 22.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.28 -53.34 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.1 t -62.07 137.81 58.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.99 -87.26 1.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 102.42 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.659 2.24 . . . . 0.0 112.28 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 89.8 p -108.89 85.56 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 12.1 t -59.53 -50.09 75.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.527 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.3 p -92.96 82.13 4.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.84 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.7 p -121.09 172.12 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.99 -64.61 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.3 m -142.98 166.47 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -40.32 -44.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -97.12 132.95 11.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.494 HH21 HG22 ' A' ' 113' ' ' THR . 6.9 ptm180 -126.78 151.04 48.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.1 mtm-85 -60.78 149.92 34.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.667 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -58.78 -42.41 94.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.748 . . . . 0.0 110.9 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.3 Cg_exo -54.01 -42.52 66.16 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.364 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.494 HG22 HH21 ' A' ' 109' ' ' ARG . 2.7 m -69.7 -44.19 70.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 118' ' ' LEU . 42.1 t -62.57 -34.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.2 mt -69.05 -45.92 69.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.82 HD21 ' C ' ' A' ' 123' ' ' HIS . 34.4 mt -60.92 -34.39 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 6.3 tmtm? -80.72 -34.65 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 114' ' ' VAL . 63.2 mt -81.81 16.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 48.73 30.14 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.756 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.0 mtp -94.11 -23.32 18.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -127.54 146.39 50.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -62.46 -72.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.82 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -123.02 179.95 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.753 ' O ' HG23 ' A' ' 128' ' ' VAL . 62.7 tp -60.39 -48.28 82.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.05 -38.37 82.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.84 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -62.86 -43.01 99.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' LEU . 87.4 t -60.37 -44.33 95.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.0 95.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.114 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -58.46 -44.26 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.667 HG22 HD23 ' A' ' 111' ' ' LEU . 69.5 t -60.62 -49.68 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.2 -26.96 65.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -83.27 20.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 43.48 40.92 5.1 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.42 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -95.81 -24.02 16.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.796 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.7 t -118.21 139.01 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 161' ' ' VAL . 7.9 ptt180 -129.46 155.76 45.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.64 HG21 ' CE2' ' A' ' 148' ' ' PHE . 38.8 t -120.06 113.02 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.96 -149.18 22.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 3.47 2.77 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.0 OUTLIER -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -90.92 115.09 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 148' ' ' PHE . 98.4 t -86.18 128.99 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 p -124.46 38.43 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' C ' HG11 ' A' ' 131' ' ' VAL . 5.5 t70 -161.87 137.59 5.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.523 0.678 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.92 28.24 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.713 2.275 . . . . 0.0 112.332 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.28 -2.04 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 138' ' ' VAL . 83.1 t80 -66.27 123.37 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.4 mt -87.56 139.17 30.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 148' ' ' PHE . 57.2 t -127.34 142.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 154' ' ' MET . 74.6 p -108.9 150.09 28.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -37.77 -30.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 151' ' ' THR . 5.0 t -72.05 -43.7 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 151' ' ' THR . 3.6 mmt -77.18 -26.73 53.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -44.61 -42.73 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.845 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.28 -24.27 59.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 154' ' ' MET . 6.2 m-85 -88.35 28.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.16 121.38 55.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -141.96 157.75 44.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.796 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.4 m95 -83.95 127.09 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 137' ' ' ARG . 62.4 t -39.87 -41.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.44 88.35 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.9 p -101.2 40.71 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -94.99 -46.4 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 166' ' ' ILE . 22.2 tptp -72.33 -36.49 68.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 165' ' ' LYS . 47.3 mm -37.36 126.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.103 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -141.02 110.68 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.62 83.15 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.448 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.88 118.94 5.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.284 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 34.5 m -76.17 124.58 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 62.2 p -66.89 114.73 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.0 p -75.48 146.85 40.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.377 . . . . 0.0 110.81 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -169.74 124.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.48 123.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.0 p -143.37 171.79 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m -125.56 50.77 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.32 140.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.533 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -129.21 158.15 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.3 mtm180 -60.79 143.71 54.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -57.2 -41.73 92.53 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.581 0.705 . . . . 0.0 110.986 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.1 Cg_exo -54.32 -42.45 67.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.0 m -69.51 -44.0 71.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 155' ' ' GLU . 58.6 t -62.81 -35.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.693 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.3 mt -68.52 -45.49 72.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' C ' ' A' ' 123' ' ' HIS . 18.0 mt -61.58 -36.0 79.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -80.3 -33.43 37.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 118' ' ' LEU . 13.2 mt -82.13 17.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 47.95 26.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.693 ' CB ' HD23 ' A' ' 115' ' ' LEU . 34.2 mmm -83.24 -36.64 24.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.74 176.85 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.2 -70.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.506 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.2 p80 -122.18 173.47 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 116' ' ' LEU . 60.3 tp -55.72 -47.45 76.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 12.8 tt0 -59.03 -35.96 74.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -69.55 -48.93 58.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -61.52 -42.84 99.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.88 -48.6 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.09 92.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 20.6 m-85 -59.43 -43.77 93.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 127' ' ' ALA . 40.8 t -60.02 -48.89 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.15 -27.38 64.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.39 -0.44 37.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.15 40.99 98.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -93.5 -29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.865 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.783 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 16.7 t -112.6 141.94 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -130.8 154.44 48.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 148' ' ' PHE . 48.5 t -117.6 112.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.47 -148.81 25.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.317 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' VAL . 5.2 m-20 -121.26 131.51 54.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.3 t -90.55 112.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 148' ' ' PHE . 87.4 t -86.48 128.44 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 p -124.31 33.29 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 147' ' ' ALA . 18.7 t70 -149.04 133.29 8.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 110.8 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -20.97 34.02 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.75 2.3 . . . . 0.0 112.294 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.463 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -78.0 9.96 3.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 143' ' ' VAL . 61.3 t80 -77.62 125.85 29.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.58 138.22 31.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' HB3' ' A' ' 154' ' ' MET . 49.0 t -127.39 142.97 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.4 p -98.96 157.67 16.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.76 -29.83 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 t -84.89 -27.9 26.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.624 ' HB3' HG13 ' A' ' 150' ' ' VAL . 8.8 tpt -80.76 -29.85 36.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 158' ' ' VAL . 99.5 mt-10 -54.45 -34.69 61.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.6 -22.53 66.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -96.68 32.36 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 155' ' ' GLU . 95.3 t -100.19 120.9 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.7 t -142.27 158.17 44.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.783 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 96.2 m95 -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.23 -45.77 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.97 111.79 14.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 89.3 p -124.31 42.73 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.1 t -79.11 -44.82 21.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -83.37 -34.35 25.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.6 mm -42.25 122.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 t -156.88 138.38 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.06 -159.83 16.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.1 20.19 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.9 p -41.39 151.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 60.4 p -113.68 112.71 23.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.485 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 m -43.48 126.49 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.1 t -164.62 127.62 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.79 144.16 46.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -68.0 -53.75 23.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.865 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.9 p -156.15 154.92 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.63 177.72 39.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.492 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -133.87 142.1 47.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 7.5 mtm-85 -60.69 151.51 29.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.4 tp -61.88 -41.89 79.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.553 0.692 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 50.9 Cg_exo -55.72 -42.41 67.69 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.593 2.195 . . . . 0.0 112.378 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.2 m -69.32 -44.2 72.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 110' ' ' ARG . 48.0 t -65.17 -35.93 76.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' CB ' ' A' ' 120' ' ' MET . 12.4 mt -66.81 -44.28 81.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 124' ' ' LEU . 75.5 mt -64.92 -35.89 82.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.2 tmtp? -80.33 -33.91 37.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 114' ' ' VAL . 14.7 mt -81.12 14.99 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 53.88 29.35 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.631 ' CB ' HD23 ' A' ' 115' ' ' LEU . 36.6 mmm -88.75 -36.58 16.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -117.02 174.58 6.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.077 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.91 -66.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.601 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.6 p80 -124.38 175.3 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 128' ' ' VAL . 51.8 tp -56.14 -44.92 79.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -64.48 -36.44 84.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -67.86 -48.92 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.864 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.71 -43.13 97.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 124' ' ' LEU . 80.1 t -65.42 -46.75 89.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.86 88.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.0 m-85 -64.65 -40.55 95.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 127' ' ' ALA . 38.8 t -61.3 -53.24 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.52 -28.17 69.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -82.19 10.74 6.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 51.55 38.84 44.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -90.95 -22.22 20.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.706 HG22 ' CE3' ' A' ' 160' ' ' TRP . 22.0 t -120.75 135.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -125.13 156.86 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.502 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.6 t -119.83 111.88 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.42 -149.04 24.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 3.56 2.74 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -121.18 129.27 53.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.92 110.04 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.603 HG11 ' CB ' ' A' ' 148' ' ' PHE . 43.1 t -83.94 131.72 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.8 p -122.28 39.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' C ' HG11 ' A' ' 131' ' ' VAL . 2.6 t70 -158.3 134.79 6.45 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.7 Cg_endo -69.8 -23.45 30.59 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.636 2.224 . . . . 0.0 112.34 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.97 5.5 5.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.044 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.603 ' CB ' HG11 ' A' ' 143' ' ' VAL . 87.9 t80 -70.15 127.63 33.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.23 139.04 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.478 HG22 ' HE2' ' A' ' 148' ' ' PHE . 42.6 t -130.61 139.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 154' ' ' MET . 15.4 t -100.78 162.3 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -52.44 -33.22 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.799 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.7 t -76.43 -35.31 58.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.687 ' H ' HG23 ' A' ' 151' ' ' THR . 5.7 tpt -81.22 -15.0 56.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -61.59 -41.3 97.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.23 -0.45 9.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.35 23.64 13.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.16 120.92 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.184 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.1 t -141.79 158.06 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.706 ' CE3' HG22 ' A' ' 136' ' ' VAL . 95.5 m95 -83.99 144.42 29.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 134' ' ' GLY . 78.7 t -55.59 -40.65 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.142 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -140.51 109.68 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.989 ' HA ' HD13 ' A' ' 166' ' ' ILE . 49.6 p -109.8 66.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.5 p -87.51 -75.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 17.0 tttp -68.66 -40.39 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.989 HD13 ' HA ' ' A' ' 163' ' ' SER . 5.2 mp -33.43 112.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.4 t -137.53 121.34 17.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.25 -159.16 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 120.53 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.698 2.266 . . . . 0.0 112.34 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.5 p -59.1 -46.39 88.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 68.4 m 62.01 41.19 11.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.555 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.2 m 62.62 43.41 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.1 m -113.44 174.61 5.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.21 -45.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.549 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.3 m -88.61 171.26 10.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.927 0.394 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 55.9 m -69.19 158.86 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.42 137.23 4.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -127.49 153.19 46.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.51 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.7 mtm180 -60.94 146.56 46.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.0 tp -55.6 -42.6 96.88 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.641 0.734 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 63.4 Cg_exo -52.47 -42.63 60.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.291 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.5 m -69.73 -43.91 71.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.21 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' OE2' ' A' ' 155' ' ' GLU . 89.2 t -59.81 -35.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.574 HD23 ' CB ' ' A' ' 120' ' ' MET . 16.0 mt -71.07 -44.47 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.906 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.546 HD21 ' C ' ' A' ' 123' ' ' HIS . 39.8 mt -61.24 -36.52 80.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -73.3 -39.19 65.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.76 22.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 48.0 25.15 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.574 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.6 mmm -77.6 -33.11 53.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.96 167.63 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -86.82 -61.97 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' C ' HD21 ' A' ' 116' ' ' LEU . 5.6 p80 -125.49 178.24 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.531 ' HA ' HD11 ' A' ' 116' ' ' LEU . 62.6 tp -62.43 -46.33 89.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -61.03 -35.9 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.513 ' HB2' ' NE2' ' A' ' 123' ' ' HIS . . . -67.13 -47.12 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -63.06 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.0 t -61.84 -46.8 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.9 -41.9 98.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 15.5 m-85 -58.06 -44.12 87.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 127' ' ' ALA . 45.2 t -62.03 -50.79 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.77 -28.88 69.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.76 21.1 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 44.09 53.21 6.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.647 ' C ' HG23 ' A' ' 161' ' ' VAL . 22.2 m-70 -107.1 -27.59 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.333 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.606 HG22 ' CE3' ' A' ' 160' ' ' TRP . 48.2 t -116.54 142.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.37 158.06 45.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 148' ' ' PHE . 61.5 t -119.92 110.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -148.97 24.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.79 3.73 2.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.267 . . . . 0.0 112.353 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' VAL . 1.1 m-20 -121.38 128.07 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.7 t -91.13 123.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 148' ' ' PHE . 45.6 t -99.54 134.61 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 p -110.07 -23.49 11.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.185 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.29 137.04 20.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -24.91 29.3 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.739 2.292 . . . . 0.0 112.362 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.23 -7.78 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.712 ' CB ' HG11 ' A' ' 143' ' ' VAL . 91.3 t80 -56.46 125.6 22.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -89.55 139.04 30.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.765 HG13 ' HB3' ' A' ' 154' ' ' MET . 75.5 t -121.91 139.94 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -102.15 158.51 16.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -47.93 -34.79 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 t -77.26 -27.62 53.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.765 ' HB3' HG13 ' A' ' 150' ' ' VAL . 2.8 tpt -84.81 -26.06 27.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 114' ' ' VAL . 15.2 mm-40 -45.85 -41.61 11.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.37 -24.78 60.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -84.75 29.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 75.7 t -103.62 120.94 54.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -141.94 158.16 44.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.606 ' CE3' HG22 ' A' ' 136' ' ' VAL . 89.9 m95 -83.87 140.15 32.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.647 HG23 ' C ' ' A' ' 135' ' ' HIS . 96.6 t -46.18 -68.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.136 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 166' ' ' ILE . 0.7 OUTLIER -110.23 -60.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 160' ' ' TRP . 68.1 p 49.72 39.49 17.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 12.2 m -109.32 -53.65 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -107.92 28.58 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -106.42 73.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 t -66.27 176.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.46 163.71 9.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 84.84 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.405 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.1 t -47.36 -53.37 13.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.799 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -165.57 167.32 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 t -84.19 -49.43 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 p -167.4 125.21 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.72 -126.41 0.84 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -94.7 164.91 12.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -52.11 139.47 23.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.19 117.65 2.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -132.02 158.98 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.497 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 5.9 mtm180 -60.9 143.81 54.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.638 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.9 tp -57.04 -41.83 93.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.8 Cg_exo -53.88 -42.52 65.89 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.713 2.275 . . . . 0.0 112.349 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.3 m -69.36 -44.08 72.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 118' ' ' LEU . 40.0 t -60.31 -35.02 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.702 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.4 mt -70.04 -46.64 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 124' ' ' LEU . 96.2 mt -60.94 -38.66 86.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 4.4 tmtm? -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 114' ' ' VAL . 80.8 mt -84.43 18.23 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 48.77 25.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.702 ' HB2' HD23 ' A' ' 115' ' ' LEU . 95.8 mtp -89.56 -19.45 24.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -128.82 153.82 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.11 -67.13 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.8 p80 -130.64 172.96 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.8 tp -52.94 -49.17 66.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.884 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 26.9 tt0 -58.98 -36.66 75.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.56 -45.38 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -65.36 -43.02 92.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 66.6 t -61.56 -47.13 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.45 90.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 12.7 m-85 -60.62 -43.28 97.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.63 HG22 HD23 ' A' ' 111' ' ' LEU . 91.4 t -64.47 -45.32 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.49 -28.41 66.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.578 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 55.8 mt-30 -83.21 18.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 42.65 42.62 4.79 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 41.9 m-70 -97.71 -25.19 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 0.0 110.845 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.584 HG22 ' CZ3' ' A' ' 160' ' ' TRP . 52.3 t -114.59 141.51 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.077 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -134.23 156.45 48.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG12 ' CE ' ' A' ' 154' ' ' MET . 99.8 t -119.86 111.99 35.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.38 -149.12 24.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 3.67 2.62 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.622 2.215 . . . . 0.0 112.399 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -121.11 131.04 54.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.3 t -91.03 127.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.786 HG21 ' CD2' ' A' ' 148' ' ' PHE . 82.3 t -100.38 136.35 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.3 p -122.77 -9.75 8.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 133.53 21.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.699 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.49 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 54.1 Cg_endo -69.73 -19.31 36.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 0.0 112.398 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.71 29.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.3 t80 -60.01 129.75 43.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.803 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.08 128.49 41.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.55 143.02 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 154' ' ' MET . 8.8 t -104.58 155.18 19.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HB3' ' NH1' ' A' ' 152' ' ' ARG . 5.5 mmm180 -42.41 -41.1 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 t -68.66 -32.17 71.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.524 ' H ' HG23 ' A' ' 151' ' ' THR . 6.4 tpt -95.72 -2.34 48.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' THR . 23.4 mt-10 -76.4 -24.82 54.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.92 -9.05 54.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -98.07 23.91 7.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 138' ' ' VAL . 30.4 t -95.03 120.97 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.6 t -142.08 157.97 44.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.078 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.584 ' CZ3' HG22 ' A' ' 136' ' ' VAL . 95.7 m95 -83.99 134.61 34.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.4 t -37.17 -32.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 160' ' ' TRP . 35.5 m-20 -150.26 106.57 3.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.597 ' HA ' HD11 ' A' ' 166' ' ' ILE . 13.3 m -106.53 86.32 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.4 t -112.33 84.88 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.1 tttp 61.32 45.53 8.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 163' ' ' SER . 69.6 mt -60.5 123.85 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 65.2 p -126.84 172.15 10.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.92 7.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.68 146.09 59.63 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 58.0 m -51.01 -39.67 56.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.8 t -68.23 124.82 24.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -90.18 85.84 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.824 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -89.21 123.81 33.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.57 89.83 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.521 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -98.46 167.66 10.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.383 . . . . 0.0 110.893 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.8 p -116.23 110.91 19.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.03 149.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.456 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -133.46 150.36 51.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.517 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 8.2 mtm-85 -60.63 144.33 52.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 131' ' ' VAL . 14.1 tp -53.96 -42.57 93.86 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 61.9 Cg_exo -52.65 -42.59 61.42 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.362 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 m -69.5 -42.5 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' OE2' ' A' ' 155' ' ' GLU . 65.5 t -59.9 -35.95 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 120' ' ' MET . 7.6 mt -71.02 -46.13 62.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.832 HD21 ' C ' ' A' ' 123' ' ' HIS . 96.1 mt -61.03 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.59 -38.97 88.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.5 mt -81.66 16.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 48.84 29.48 2.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.664 ' HB2' HD23 ' A' ' 115' ' ' LEU . 84.3 mtp -89.09 -22.04 23.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -125.73 139.0 53.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.555 ' HG3' ' CD2' ' A' ' 123' ' ' HIS . 19.6 pt20 -56.04 -49.96 72.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.832 ' C ' HD21 ' A' ' 116' ' ' LEU . 2.5 p80 -151.96 177.16 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 128' ' ' VAL . 40.6 tp -56.07 -40.15 73.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.04 -44.06 91.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.93 -46.31 62.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.67 -43.0 94.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 124' ' ' LEU . 89.7 t -66.46 -48.65 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.71 98.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 13.5 m-85 -58.03 -44.82 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.655 HG22 HD23 ' A' ' 111' ' ' LEU . 53.3 t -58.79 -50.5 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.25 -27.67 67.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 30.1 mt-30 -85.68 24.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 39.13 46.45 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.52 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.567 ' C ' HG23 ' A' ' 161' ' ' VAL . 24.2 m-70 -100.23 -21.69 15.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.752 HG22 ' CE3' ' A' ' 160' ' ' TRP . 62.9 t -121.58 137.99 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -128.43 156.54 43.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.01 111.17 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.31 -148.88 24.42 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 3.53 2.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.97 130.38 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -90.61 115.61 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 145' ' ' ASP . 47.5 t -86.78 131.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.06 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.5 p -123.33 27.63 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' H ' HG12 ' A' ' 143' ' ' VAL . 6.0 t70 -151.17 135.02 9.34 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 110.769 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.482 ' N ' HG11 ' A' ' 131' ' ' VAL . 54.0 Cg_endo -69.74 -27.36 26.64 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.65 2.233 . . . . 0.0 112.402 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.59 -3.88 7.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.99 127.06 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -87.37 139.16 30.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 154' ' ' MET . 85.1 t -127.38 124.44 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 69.4 p -96.69 177.58 5.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -57.04 -13.12 2.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 t -91.52 -40.1 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.771 ' CB ' HG13 ' A' ' 150' ' ' VAL . 8.6 mmt -76.39 -34.9 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' HG12 ' A' ' 150' ' ' VAL . 23.2 mm-40 -43.66 -50.47 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.08 -30.97 71.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -84.59 33.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.02 120.86 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 158.0 44.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.752 ' CE3' HG22 ' A' ' 136' ' ' VAL . 70.4 m95 -84.12 135.95 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 135' ' ' HIS . 74.7 t -53.77 -56.18 10.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -121.86 -54.39 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 t 62.41 46.85 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.3 t -105.24 -45.42 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -128.54 37.04 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.63 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.2 pp -91.12 167.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 p -105.32 119.91 40.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -164.06 -156.3 8.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 2.82 3.2 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.624 2.216 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -40.14 -42.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 71.8 m -141.0 150.16 42.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.5 p -100.14 158.35 15.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.0 m -143.38 150.2 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.66 -46.63 1.02 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -79.99 170.41 16.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.841 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 m -127.6 -65.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -124.98 146.25 16.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.533 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -133.02 154.99 50.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.509 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 3.1 mtt180 -60.83 149.14 36.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 14.2 tp -59.41 -42.07 90.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.7 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 53.2 Cg_exo -54.02 -42.64 65.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.6 m -69.2 -44.2 72.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.1 t -60.08 -34.96 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 120' ' ' MET . 8.8 mt -69.93 -46.74 64.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.444 HD21 ' C ' ' A' ' 123' ' ' HIS . 92.2 mt -60.92 -41.07 95.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 117' ' ' LYS . 1.8 tmtp? -72.81 -35.74 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.2 mt -82.81 19.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 44.95 28.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 115' ' ' LEU . 98.1 mtp -88.55 -21.8 23.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.1 169.51 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.59 -59.49 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.519 ' CE1' ' HB3' ' A' ' 125' ' ' GLN . 5.2 p80 -134.7 173.22 11.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 128' ' ' VAL . 67.3 tp -57.68 -44.35 85.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 8.6 tt0 -59.15 -36.5 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.592 ' O ' ' CD2' ' A' ' 130' ' ' PHE . . . -70.72 -48.73 53.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -59.6 -43.12 93.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 124' ' ' LEU . 94.1 t -66.72 -47.66 82.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.95 92.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 126' ' ' ALA . 17.5 m-85 -61.9 -42.97 99.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 127' ' ' ALA . 89.2 t -62.9 -45.27 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.41 -30.81 71.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.19 13.74 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 50.69 43.8 47.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -95.54 -23.33 17.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.739 HG22 ' CE3' ' A' ' 160' ' ' TRP . 21.6 t -118.95 138.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.44 157.56 43.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 148' ' ' PHE . 96.8 t -120.08 112.91 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.88 -149.28 21.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.548 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 3.62 2.71 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -120.39 129.9 54.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.845 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.5 t -90.44 123.46 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 148' ' ' PHE . 50.9 t -101.13 136.23 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 p -120.6 -11.6 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 8.6 t70 -103.44 130.02 24.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.59 0.709 . . . . 0.0 110.845 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 53.8 Cg_endo -69.73 -15.92 37.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.582 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -82.41 11.41 5.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.067 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.495 ' CD2' HG21 ' A' ' 143' ' ' VAL . 45.4 t80 -75.44 125.77 29.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.98 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.979 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 154' ' ' MET . 43.3 t -124.94 142.44 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' MET . 70.7 p -98.49 149.67 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -44.49 -30.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.3 m -80.8 -33.85 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 150' ' ' VAL . 5.8 tpt -79.03 -25.12 43.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' VAL . 75.3 mt-10 -53.56 -40.5 65.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.52 -21.96 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -95.01 30.81 2.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 155' ' ' GLU . 88.5 t -103.2 122.07 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -141.0 158.04 44.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.739 ' CE3' HG22 ' A' ' 136' ' ' VAL . 86.3 m95 -85.03 146.57 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.45 -54.68 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.053 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -109.72 -32.09 7.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -87.67 38.26 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 t -71.73 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' ILE . 13.0 tptm -58.26 -48.41 80.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 165' ' ' LYS . 48.3 mm -35.2 -49.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.21 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.7 p -122.57 102.29 7.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 164.36 83.45 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -1.85 9.14 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.278 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 66.6 m -44.08 130.3 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.2 t -56.95 -57.22 13.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.519 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.2 p -101.62 89.89 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m -108.13 96.1 6.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.06 -53.54 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.41 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.7 p -51.35 -38.48 53.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.3 p -80.48 138.43 36.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.37 116.82 1.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -123.49 154.73 38.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.512 ' CB ' ' HD2' ' A' ' 112' ' ' PRO . 12.2 mtm180 -60.67 145.0 50.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.633 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 13.7 tp -55.14 -42.46 96.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.573 0.701 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 111' ' ' LEU . 60.7 Cg_exo -52.33 -42.79 58.41 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.747 2.298 . . . . 0.0 112.335 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 m -69.63 -44.22 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.423 HG21 ' HB ' ' A' ' 150' ' ' VAL . 45.7 t -60.06 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.625 HD23 ' CB ' ' A' ' 120' ' ' MET . 10.4 mt -71.13 -46.16 62.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 123' ' ' HIS . 75.6 mt -61.99 -33.33 74.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.51 -38.06 59.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.3 mt -83.86 22.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 49.46 26.93 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.625 ' CB ' HD23 ' A' ' 115' ' ' LEU . 32.8 mmm -81.91 -35.84 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -121.93 174.72 6.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -95.12 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.487 ' C ' HD21 ' A' ' 116' ' ' LEU . 4.0 p80 -125.4 174.21 8.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 128' ' ' VAL . 53.3 tp -57.25 -42.86 82.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.37 -39.08 91.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.24 -47.32 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -65.55 -42.21 92.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 124' ' ' LEU . 69.7 t -61.56 -45.6 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.093 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.49 97.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -61.14 -42.09 97.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 127' ' ' ALA . 54.3 t -59.61 -53.61 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.181 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.9 -19.62 65.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 13.1 mt-30 -92.67 21.02 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.567 ' O ' HG21 ' A' ' 161' ' ' VAL . . . 40.04 42.59 2.34 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.498 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 133' ' ' GLN . 24.9 m-70 -95.13 -22.9 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.825 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.674 HG22 ' CE3' ' A' ' 160' ' ' TRP . 19.1 t -121.36 142.77 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -132.25 156.52 46.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.05 112.57 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 55.05 -149.16 22.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.65 3.45 2.71 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.52 130.32 54.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.3 t -90.99 110.62 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.575 HG11 ' CG ' ' A' ' 148' ' ' PHE . 60.5 t -93.6 132.85 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.443 ' C ' HG12 ' A' ' 131' ' ' VAL . 70.0 p -122.47 -5.69 8.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 147' ' ' ALA . 13.4 t70 -97.38 130.06 30.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 131' ' ' VAL . 54.2 Cg_endo -69.76 -16.8 37.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.658 2.238 . . . . 0.0 112.313 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . . . -89.1 7.85 32.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.575 ' CG ' HG11 ' A' ' 143' ' ' VAL . 86.7 t80 -69.48 125.32 26.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.07 139.03 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.767 HG13 ' CB ' ' A' ' 154' ' ' MET . 76.8 t -121.42 131.5 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.6 p -97.71 172.2 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -53.88 -18.11 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 p -88.4 -39.55 14.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.767 ' CB ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -75.56 -23.71 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 150' ' ' VAL . 24.0 mm-40 -56.33 -54.68 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.05 0.4 16.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -111.24 24.1 13.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' MET . 93.4 t -95.01 120.98 45.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.2 t -141.28 157.92 44.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 136' ' ' VAL . 94.1 m95 -84.31 131.73 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 134' ' ' GLY . 56.0 t -37.3 -48.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -131.62 111.49 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.3 p -103.7 51.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 t -88.88 -59.88 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -122.85 41.39 3.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.2 pp -86.61 160.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 53.4 p -73.69 100.37 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.47 147.21 4.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.85 -14.62 36.03 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.232 . . . . 0.0 112.272 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.9 p 52.7 41.46 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.5 t -87.57 112.93 22.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.922 . . . . . . . . 0 0 . 1 stop_ save_